🏷

Classifications

Harrison's Part

👪

Inheritance

2

Autosomal Recessive HP:0000007

The usual pattern for primary congenital glaucoma, covering the CYP1B1 (GLC3A) and LTBP2 (GLC3C/GLC3D) routes. Penetrance is incomplete and expressivity variable, so an obligate homozygote may be only mildly affected. Familial cases are strongly associated with consanguinity, but most cases worldwide are sporadic.

Autosomal recessive inheritance Penetrance: INCOMPLETE

Show evidence (2 references)

PMID:20301314 SUPPORT Other

"PCG caused by biallelic pathogenic variants in CYP1B1 or LTBP2 is inherited in an autosomal recessive manner. PCG caused by a heterozygous pathogenic variant in TEK is inherited in an autosomal dominant manner."

States the recessive inheritance of the CYP1B1 and LTBP2 forms, and contrasts it with the dominant TEK form recorded separately below. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

PMID:9463332 SUPPORT Human Clinical

"Formal linkage analysis in 25 Saudi PCG families confirmed both significant linkage to polymorphic markers in this region and incomplete penetrance, but it showed no evidence of genetic heterogeneity."

Documents incomplete penetrance directly in a linkage-confirmed GLC3A/CYP1B1 cohort, supporting the penetrance value recorded here.

Autosomal Dominant HP:0000006

The pattern for TEK-related congenital glaucoma (GLC3E), which acts through haploinsufficiency rather than biallelic loss. Expressivity is markedly variable, so a heterozygous parent may be unaffected or only mildly affected and the pedigree can be mistaken for a sporadic or recessive one.

Autosomal dominant inheritance Expressivity: VARIABLE

Show evidence (1 reference)

PMID:27270174 SUPPORT Human Clinical

"these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."

States both the autosomal dominant transmission and the variable expressivity recorded on this inheritance block.

◆

Subtypes

8

clinical phenotype

Primary Congenital Glaucoma (nonsyndromic) MONDO:0000365

Isolated, nonsyndromic developmental glaucoma with onset from birth to age three, caused by an isolated dysgenesis of the trabecular meshwork and iridocorneal angle with no other ocular or systemic anomaly. This is the parent of the numbered GLC3 subtypes below and the most common childhood glaucoma. Inheritance is usually autosomal recessive with incomplete penetrance and a strong association with consanguinity, but the majority of cases worldwide are sporadic.

Show evidence (2 references)

PMID:28549150 SUPPORT Other

"Primary congenital glaucoma (PCG) is isolated, non-syndromic glaucoma that occurs in the first three years of life and is a major cause of childhood blindness."

Defines PCG as isolated, non-syndromic, and occurring in the first three years, which is the boundary this subtype draws against the secondary forms. Evidence source is OTHER because this is a genetics review.

PMID:39941238 SUPPORT Other

"PCG is considered the most common glaucoma in children, not associated with other syndromic manifestations. Usually, it is inherited in an autosomal recessive manner, with a positive family history in cases of consanguinity"

Supports the non-syndromic definition and the recessive/consanguinity pattern recorded in this subtype. Evidence source is OTHER because this is a clinical review.

Congenital Glaucoma Secondary to Non-Acquired Anterior Segment Dysgenesis

FOXC1 hgnc:3800 PITX2 hgnc:9005 PAX6 hgnc:8620

Congenital and infantile glaucoma occurring as a complication of a non-acquired ocular anomaly of the anterior segment -- principally the Axenfeld-Rieger spectrum (PITX2, FOXC1), Peters anomaly (PAX6, FOXC1, PITX2, CYP1B1, B3GLCT and others), and PAX6-related aniridia. In the CGRN scheme these are secondary rather than primary childhood glaucomas, and in genomically characterised childhood-glaucoma cohorts they outnumber PCG. The underlying syndromes have their own dismech entries (Axenfeld-Rieger_syndrome, Peters_Plus_Syndrome); this subtype exists to hold the shared route by which their angle anomaly becomes congenital glaucoma, and the mechanism is not always the same as in PCG -- adhesional angle closure can operate alongside, or instead of, trabeculodysgenesis.

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"whereases secondary childhood glaucomas include those associated with non-acquired ocular anomalies (such as Axenfeld-Rieger spectrum (ARS), aniridia, and Peters anomaly)"

Establishes the CGRN secondary category and names the three anomalies this subtype covers. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:38755526 SUPPORT Human Clinical

"Twenty-five percent (5/20) of the solved families had primary congenital glaucoma (PCG), while 75% (15/20) had secondary CG"

Supports the claim that secondary forms outnumber PCG in a genomically characterised childhood-glaucoma cohort.

molecular

GLC3A - CYP1B1-related Primary Congenital Glaucoma MONDO:0009277

CYP1B1 hgnc:2597

Autosomal recessive PCG mapping to 2p21 and caused by biallelic CYP1B1 variants. CYP1B1 is by far the most frequently implicated gene in congenital glaucoma worldwide, though its share of cases is strongly population-dependent, being highest in consanguineous and founder populations and much lower in outbred cohorts. Penetrance is incomplete and expressivity is variable, so mildly affected relatives of a proband can be missed.

Show evidence (2 references)

PMID:9097971 SUPPORT Human Clinical

"The mutations detected in the affected members of these families were not present in 470 chromosomes from randomly selected normal individuals, thus strongly suggesting that CYP1B1 is the gene for the GLC3A locus on 2p21."

Establishes CYP1B1 as the GLC3A gene, which is the definition of this subtype.

PMID:38386645 SUPPORT Human Clinical

"CYP1B1 variants were associated with region and population-specific prevalence ranging from 5% to 86% among those with primary congenital glaucoma."

Quantifies the population dependence of the CYP1B1 contribution asserted in this subtype description.

GLC3B - 1p36-linked Primary Congenital Glaucoma MONDO:0010968

A second autosomal recessive PCG locus mapped by linkage to 1p36.2-36.1 in families unlinked to GLC3A. The GLC3B gene has still not been identified, which is why this subtype is defined by locus rather than by gene; the same linkage study also showed that families unlinked to both 2p21 and 1p36 exist, establishing further locus heterogeneity.

Show evidence (2 references)

PMID:8842741 SUPPORT Human Clinical

"Herein, we describe mapping of a new locus (designated GLC3B) for primary congenital glaucoma to the short arm of chromosome 1 (1p36.2-36.1)"

The original mapping of GLC3B to 1p36, which is what defines this locus-based subtype.

PMID:8842741 SUPPORT Human Clinical

"the remaining four families are not linked to this part of chromosome 1, thus providing further evidence that at least one more locus for the autosomal recessive form of GLC3 must exist in the genome."

Supports the further locus heterogeneity noted in this subtype's description.

GLC3C - 14q24-linked Primary Congenital Glaucoma MONDO:0013121

A third autosomal recessive PCG locus on 14q24. LTBP2, which lies about 1.3 Mb proximal to the documented GLC3C interval, harbours null mutations that cause PCG; whether LTBP2 is the GLC3C gene itself or an adjacent second gene at the locus was left unresolved by the original report and is recorded here as an open question rather than a settled equivalence.

Show evidence (1 reference)

PMID:19361779 SUPPORT Human Clinical

"LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG."

States the unresolved relationship between LTBP2 and the GLC3C locus that is the reason this subtype is kept separate from GLC3D.

GLC3D - LTBP2-related Primary Congenital Glaucoma MONDO:0013122

LTBP2 hgnc:6715

Autosomal recessive PCG caused by biallelic null mutations in LTBP2 at 14q24.3, reported in consanguineous Pakistani families and in patients of Roma ethnicity. LTBP2 is an extracellular matrix protein of the latent TGF-beta binding protein family with homology to the fibrillins; its loss appears to be a structural rather than a signalling defect of the anterior segment.

Show evidence (2 references)

PMID:19361779 SUPPORT Human Clinical

"Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."

Establishes biallelic LTBP2 null mutations as the cause of this subtype in the populations named.

PMID:19361779 SUPPORT Human Clinical

"LTBP2 is the largest member of the latent transforming growth factor (TGF)-beta binding protein family, which are extracellular matrix proteins with multidomain structure. It has homology to fibrillins and may have roles in cell adhesion and as a structural component of microfibrils."

Supports the fibrillin-homology and microfibril description given for this subtype.

GLC3E - TEK-related Primary Congenital Glaucoma MONDO:0014998

TEK hgnc:11724

PCG caused by heterozygous loss-of-function variants in TEK (TIE2), the endothelial angiopoietin receptor. Unlike the other GLC3 subtypes this one is autosomal dominant, acting through haploinsufficiency with markedly variable expressivity, so an obligate carrier parent may be unaffected or only mildly affected. The lesion is vascular-developmental: the Schlemm canal, a hybrid vessel with lymphatic and venous features, fails to form properly.

Show evidence (2 references)

PMID:27270174 SUPPORT Human Clinical

"these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."

Establishes the dominant, variably expressive inheritance that separates this subtype from the other GLC3 loci.

PMID:29106382 SUPPORT Other

"Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm's canal (SC) and the trabecular meshwork."

Supports the anatomical premise of this subtype, that congenital glaucoma arises from developmental failure of Schlemm canal alongside the trabecular meshwork. Evidence source is OTHER because this is the paper's framing statement of established etiology rather than its own result.

ANGPT1-related Primary Congenital Glaucoma

ANGPT1 hgnc:484

PCG attributable to rare variants in ANGPT1, the principal ligand of the TEK receptor, identified in a small number of subjects within a large international PCG cohort. Mechanistically this is the ligand-side counterpart of GLC3E and converges on the same Schlemm canal developmental defect; ANGPT2 is dispensable on its own but compensates for ANGPT1 loss, which is consistent with the rarity of ANGPT1-only disease. No separate numbered GLC3 locus or MONDO subtype term has been assigned.

Show evidence (2 references)

PMID:29106382 SUPPORT Human Clinical

"In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients."

Gives the human genetic basis and the rarity of this subtype.

PMID:29106382 SUPPORT Model Organism

"ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1"

Supports the ligand-redundancy explanation this subtype gives for its own rarity.

?

Discussions and Knowledge Gaps

2

Is CYP1B1 expressed in the trabecular meshwork itself, or does it act on the developing outflow apparatus from the ciliary body and neuroepithelium?

CONTROVERSY OPEN cyp1b1_expression_site

Attached to

pathophysiology#CYP1B1 Deficiency in the Developing Anterior Segment

The two published answers are directly contradictory. The original GLC3A mapping paper reports demonstrating CYP1B1 expression in trabecular meshwork cells; a later cohort study states expression is found in fetal and adult ciliary body and neuroepithelium but not in the trabecular meshwork, and a 2024 review describes trabecular expression as controversial. The disagreement is mechanistically load-bearing rather than a bookkeeping detail: cell-autonomous action within the meshwork implies a different therapeutic target from a diffusible metabolite generated elsewhere in the anterior segment and acting on the meshwork at a distance. This entry therefore records the CYP1B1 node's mechanism as an unresolved metabolic route rather than asserting a site of action, and the expression evidence is marked PARTIAL.

Proposed experiments

Single-cell transcriptomic mapping of CYP1B1 in the developing human anterior segment

exp_cg_cyp1b1_expression_scrnaseq

Single-cell or spatial transcriptomic profiling of human fetal iridocorneal angle across the developmental window in which the meshwork forms, reporting CYP1B1 per annotated cell type, would settle whether trabecular expression exists at the developmentally relevant stage. Both conflicting reports rest on bulk or adult tissue, where a transient fetal signal in a small cell population could be missed.

Show evidence (3 references)

PMID:9097971 SUPPORT In Vitro

"CYP1B1 gene has previously been mapped within the GLC3A candidate region and its expression in the trabecular meshwork cells has been demonstrated in this study."

The report of trabecular meshwork expression that forms one side of this controversy. Evidence source is IN_VITRO because this is a tissue expression experiment.

PMID:23218701 REFUTE Other

"Studies have demonstrated its expression in fetal and adult ciliary body and neuroepithelium, but not in the trabecular meshwork."

The opposing statement, denying trabecular expression and placing CYP1B1 in the ciliary body and neuroepithelium instead. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:38755526 SUPPORT Other

"its expression in the TM remains controversial"

A contemporary source that characterises the question as still open, supporting keeping this discussion OPEN rather than resolving it either way. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

How faithfully does the Cyp1b1-null mouse model the human CYP1B1 congenital glaucoma phenotype, given that its severity depends on tyrosinase genotype and can be pharmacologically rescued?

HUMAN MODEL MISMATCH OPEN cyp1b1_mouse_phenotype_fidelity

Attached to

pathophysiology#CYP1B1 Deficiency in the Developing Anterior Segment

Cyp1b1-null mice do develop ocular drainage structure abnormalities resembling human disease, so the model is informative. But the magnitude of that dysgenesis is set by a second locus, Tyr, and the severe phenotype in doubly deficient eyes is alleviated by administering the tyrosinase product L-DOPA. That makes the mouse phenotype a property of a particular strain background as much as of CYP1B1 loss. Whether an analogous modifier axis operates in humans is unknown, and it bears directly on how much weight the mouse rescue result can carry as a therapeutic lead. Human CYP1B1 disease does show incomplete penetrance and variable expressivity, which is consistent with modifiers existing but does not identify them or establish that the tyrosinase pathway is among them.

Proposed experiments

Test the tyrosinase/L-DOPA axis as a modifier in human CYP1B1 congenital glaucoma

exp_cg_tyr_modifier_founder_cohort

Genotype pigmentation-pathway loci, TYR foremost, in a cohort of patients homozygous for the same founder CYP1B1 allele but discordant for disease severity. A founder population is required so that the CYP1B1 allele is held constant while severity varies; the Slovakian Roma and Saudi cohorts are the natural settings.

Show evidence (2 references)

PMID:12624268 SUPPORT Model Organism

"The severe dysgenesis in eyes lacking both CYP1B1 and TYR was alleviated by administration of the tyrosinase product dihydroxyphenylalanine (l-dopa)."

Documents the pharmacological rescue whose translational validity this mismatch discussion questions.

PMID:9463332 SUPPORT Human Clinical

"These results should stimulate a study of the genetic and environmental events that modify the effects of CYP1B1 mutations in ocular development."

The human authors' own call for modifier studies, consistent with modifiers operating in humans but not identifying them. Marked PARTIAL because it motivates rather than answers the question.

⚙

Pathophysiology

13

Neural Crest-Derived Periocular Mesenchyme Maldevelopment

The trabecular meshwork, corneal endothelium and stroma, iris stroma, and ciliary body all derive from cranial neural crest cells that migrate around the optic cup as periocular mesenchyme. Congenital glaucoma is at root a neurocristopathy of that migration and differentiation programme: when the periocular mesenchyme fails to remodel normally into the drainage apparatus, the outflow structures are abnormal from the outset rather than degenerating later. This is the common developmental origin shared by primary congenital glaucoma and the anterior segment dysgenesis syndromes, and it explains why the same transcription factors (FOXC1, PITX2, PAX6) recur across both.

Migratory Cranial Neural Crest Cell CL:0000008

Neural Crest Cell Migration GO:0001755 ⚠ ABNORMAL Trabecular Meshwork Development GO:0002930 ⚠ ABNORMAL

Periocular Mesenchyme UBERON:0004017 Iridocorneal Angle UBERON:0006206

Downstream

Trabeculodysgenesis and Congenital Outflow Obstruction

Secondary Angle Obstruction in Anterior Segment Dysgenesis

Show evidence (4 references)

PMID:26043871 SUPPORT Other

"Indeed, abnormalities in neural crest development cause craniofacial defects and ocular anomalies, such as Axenfeld-Rieger syndrome and primary congenital glaucoma."

Establishes defective neural crest development as the shared developmental origin of both primary congenital glaucoma and the anterior segment dysgenesis syndromes, which is the claim this trigger node makes. Evidence source is OTHER because this is a developmental-biology review.

PMID:26043871 SUPPORT Other

"These cells give rise to portions of the corneal endothelium and stroma, iris stroma, ciliary body stroma and muscles, sclera, and trabecular meshwork of the eye"

Confirms that the trabecular meshwork and the other anterior segment structures affected in congenital glaucoma are neural crest derivatives, grounding the cell-type annotation on this node. Evidence source is OTHER because this is a review.

PMID:38755526 SUPPORT Other

"Defects in the TM and the iridocorneal angle of the anterior chamber, caused by maldevelopment of neural crest tissues, can hinder the drainage process leading to fluid accumulation in the anterior chamber with resultant raised IOP"

States the causal step from neural crest maldevelopment to obstructed drainage and raised intraocular pressure, linking this trigger to the downstream outflow node. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

+ 1 more reference

CYP1B1 Deficiency in the Developing Anterior Segment

Biallelic loss-of-function variants in CYP1B1, a cytochrome P450 monooxygenase at the GLC3A locus on 2p21, are the single most common molecular cause of congenital glaucoma. The reported mutations are frameshift and other null alleles predicted to remove domains essential for enzyme function, so the mechanism is loss of a metabolic activity rather than a toxic gain of function -- which distinguishes CYP1B1 disease from the misfolding MYOC mechanism of juvenile open-angle glaucoma. How that metabolic loss translates into dysgenesis is not settled; the leading proposal is that CYP1B1 generates or clears a diffusible retinoid or other oxygenated signalling molecule required for the proliferation and differentiation of the developing anterior segment. Cyp1b1-null mice reproduce the human drainage structure abnormalities, and the severity of that phenotype is modified by tyrosinase, indicating that CYP1B1 acts within a modifiable pathway rather than as a deterministic switch -- consistent with the incomplete penetrance and variable expressivity seen in human families.

Genetic context CYP1B1 hgnc:2597 variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION

Retinoid Metabolic Process GO:0001523 ↓ DECREASED

Monooxygenase Activity GO:0004497 ⇓ LOSS OF FUNCTION

Anterior Chamber of Eyeball UBERON:0001766

Downstream

Trabeculodysgenesis and Congenital Outflow Obstruction

Show evidence (6 references)

PMID:9097971 SUPPORT Human Clinical

"All of these are frameshift mutations that are predicted to remove domains essential for the function of the CYP1B1 protein."

Establishes that the founding CYP1B1 congenital-glaucoma alleles are predicted functional nulls, supporting the loss-of-function functional_impact_category recorded on this node.

PMID:9097971 SUPPORT Human Clinical

"CYP1B1 gene has previously been mapped within the GLC3A candidate region and its expression in the trabecular meshwork cells has been demonstrated in this study."

Reports CYP1B1 expression in trabecular meshwork cells, which would place the enzyme in the affected tissue. Marked PARTIAL because later work disputes trabecular expression; see the KNOWLEDGE_GAP discussion cyp1b1_expression_site.

PMID:38755526 SUPPORT Other

"CYP1B1 has also been implicated in both vitamin A metabolism and transcription induction of genes necessary for the proliferation and differentiation of multiple ocular elements"

Supports the proposed metabolic/retinoid route by which CYP1B1 loss disturbs anterior segment proliferation and differentiation. Evidence source is OTHER because this statement is from the paper's review-style introduction rather than its own cohort data.

+ 3 more references

Angiopoietin-TEK Signaling Insufficiency and Schlemm Canal Hypoplasia

A mechanistically distinct route to the same outflow failure runs through the vascular development of Schlemm canal rather than through the trabecular mesenchyme. Schlemm canal is a hybrid vessel with lymphatic and venous features, and its formation depends on angiopoietin ligand signalling through the endothelial receptor tyrosine kinase TEK (TIE2). Heterozygous TEK loss-of-function variants cause congenital glaucoma by haploinsufficiency, with several different cellular routes to that shared endpoint -- absent protein production, aggregation, accelerated proteasomal degradation, mislocalisation, and blunted ligand responsiveness. Rare variants in the ligand ANGPT1 act on the same axis from the other side. Because the defect is gene-dosage-sensitive rather than all-or-none, expressivity is variable and inheritance is autosomal dominant, unlike the recessive CYP1B1 and LTBP2 routes.

Schlemm's Canal Endothelial Cell CL:4033097

Genetic context TEK hgnc:11724 variant_origin: GERMLINE zygosity: HETEROZYGOUS functional_impact_category: LOSS_OF_FUNCTION

Tie Signaling Pathway GO:0048014 ↓ DECREASED Vasculature Development GO:0001944 ⚠ ABNORMAL

Canal of Schlemm UBERON:0004029

Animal models

Angpt1-knockout mouse Mouse recapitulates Reproduces both halves of this node: a hypomorphic Schlemm canal and the resulting raised intraocular pressure.

Downstream

Trabeculodysgenesis and Congenital Outflow Obstruction

Show evidence (6 references)

PMID:27270174 SUPPORT Human Clinical

"Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function."

Establishes TEK haploinsufficiency as a cause of congenital glaucoma in a substantial human cohort, the human anchor for this node.

PMID:27270174 SUPPORT Model Organism

"hemizygosity for Tek led to the formation of severely hypomorphic Schlemm's canal and trabecular meshwork, as well as elevated IOP, demonstrating that anterior chamber vascular development is sensitive to Tek gene dosage"

Demonstrates in mice that Tek gene dosage controls Schlemm canal and trabecular meshwork formation and intraocular pressure, supporting the dosage-sensitivity claim in the description.

PMID:27270174 SUPPORT Human Clinical

"these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."

Supports the autosomal dominant, variably expressive inheritance recorded for the GLC3E subtype, in contrast with the recessive CYP1B1/LTBP2 routes.

+ 3 more references

LTBP2 Loss and Anterior Segment Microfibril Deficiency

LTBP2, the largest member of the latent TGF-beta binding protein family, is an extracellular matrix protein with homology to the fibrillins and a probable role as a structural component of microfibrils. Biallelic null mutations cause congenital glaucoma in consanguineous Pakistani and Roma families. LTBP2 localises to the anterior segment at the ciliary body and particularly the ciliary process, and the proposal is that its loss compromises the structural integrity of the anterior chamber and ciliary muscle tone rather than disturbing a signalling cascade -- making this an extracellular-matrix route to outflow failure, mechanistically parallel to but separate from the metabolic (CYP1B1) and vascular (TEK/ANGPT1) routes.

Genetic context LTBP2 hgnc:6715 variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION

Extracellular Matrix Organization GO:0030198 ⚠ ABNORMAL

Anterior Chamber of Eyeball UBERON:0001766

Downstream

Trabeculodysgenesis and Congenital Outflow Obstruction

Show evidence (3 references)

PMID:19361779 SUPPORT Human Clinical

"Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."

Establishes biallelic LTBP2 null mutations as a cause of congenital glaucoma, the human genetic basis of this node.

PMID:19361779 SUPPORT In Vitro

"We confirmed localization of LTBP2 in the anterior segment of the eye, at the ciliary body, and particularly the ciliary process."

Places the LTBP2 protein in the anterior segment tissue affected in congenital glaucoma, supporting the anatomical annotation on this node. Evidence source is IN_VITRO because this is a tissue localisation experiment.

PMID:19361779 SUPPORT Human Clinical

"These findings reveal that LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone."

States the proposed structural rather than signalling role for LTBP2 in anterior chamber development, as asserted in this node's description.

Trabeculodysgenesis and Congenital Outflow Obstruction

The convergence point of the primary congenital routes. Instead of the acquired juxtacanalicular extracellular matrix accumulation and trabecular cell loss that raise outflow resistance in adult open-angle glaucoma, the congenital lesion is an angle that never matured: gonioscopy shows an immature appearance of arrested development, with a high flat iris insertion, peripheral scalloping, and circumferential iris vessels. Resistance to aqueous egress is therefore abnormal from birth. This node substitutes the disorder-specific developmental lesion into the module's conserved outflow-dysfunction step; the module's own trabecular-ECM-accumulation annotation is deliberately not copied here, because the mechanism is dysgenetic rather than degenerative.

Trabecular Meshwork Cell CL:0002367

Trabecular Meshwork Development GO:0002930 ⚠ ABNORMAL

Eye Trabecular Meshwork UBERON:0005969 Iridocorneal Angle UBERON:0006206

Animal models

Cyp1b1-null mouse Mouse recapitulates Reproduces the maldeveloped conventional outflow pathway that is the proximate lesion in CYP1B1-related disease.

Zebrafish cyp1b1 knockout Zebrafish fails to recapitulate Adult mutant eye morphology, including the anterior chamber angle and cornea, is indistinguishable from wild type. The model is informative about CYP1B1 metabolic function but is not a phenocopy of congenital glaucoma, and must not be cited as evidence that CYP1B1 loss produces angle dysgenesis.

Downstream

Congenital Intraocular Pressure Elevation

Show evidence (2 references)

PMID:9463332 SUPPORT Human Clinical

"The autosomal recessive disorder primary congenital glaucoma (PCG) is caused by unknown developmental defect(s) of the trabecular meshwork and anterior chamber angle of the eye."

Identifies a developmental defect of the trabecular meshwork and anterior chamber angle -- not an acquired degeneration -- as the causal lesion, which is the substitution this node makes into the module's outflow-dysfunction step.

PMID:38755526 SUPPORT Other

"Gonioscopy can reveal that the angle has an immature appearance of arrested development with a high flat iris insertion, with peripheral scalloping and circumferential iris vessels"

Provides the direct clinical description of arrested angle development that distinguishes congenital trabeculodysgenesis from the adult trabecular lesion. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Secondary Angle Obstruction in Anterior Segment Dysgenesis

The parallel route taken by congenital glaucoma arising in a non-acquired anterior segment anomaly. Here outflow can fail by two mechanisms that are not interchangeable: trabeculodysgenesis of the kind seen in primary congenital glaucoma, and adhesional angle closure in which iridocorneal or lenticulocorneal adhesions physically obliterate the drainage angle. Which operates depends on the anomaly and its severity -- in Peters anomaly the risk of glaucoma rises steeply with the degree of anterior segment dysgenesis, from none in eyes with an isolated posterior corneal defect to the majority of eyes once lens abnormalities are present. In PAX6-related aniridia the mechanism remains genuinely unsettled, with congenital trabecular dysfunction, progressive angle closure, and postoperative ocular hypertension all proposed. This distinction matters therapeutically: angle incision surgery addresses a dysgenetic meshwork but not an obliterated angle.

Camera-Type Eye Development GO:0043010 ⚠ ABNORMAL

Iridocorneal Angle UBERON:0006206 Cornea UBERON:0000964

Downstream

Congenital Intraocular Pressure Elevation

Show evidence (4 references)

PMID:37834882 SUPPORT Other

"The pathogenesis of glaucoma secondary to Peters anomaly is thought to result from trabeculodysgenesis or angle closure mechanisms associated with iridocorneal and lenticulocorneal adhesions"

States the two alternative mechanisms -- dysgenetic meshwork versus adhesional angle closure -- that this node asserts are not interchangeable. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:37834882 SUPPORT Human Clinical

"Stage 1 Peters anomaly had no glaucoma, 52% of Stage 2 had glaucoma, and 75% of Stage 3 had glaucoma."

Quantifies the dose-response between severity of anterior segment dysgenesis and glaucoma risk that this node's description asserts.

PMID:39368260 SUPPORT Other

"the advent of new anterior segment imaging techniques has allowed the identification of various potential mechanisms: congenital trabecular dysfunction, progressive closure of the iridocorneal angle, postoperative ocular hypertension."

Documents that in PAX6-related congenital aniridia several competing mechanisms remain on the table, supporting the description's statement that the aniridia route is unsettled. Evidence source is OTHER because this is a literature review.

+ 1 more reference

Congenital Intraocular Pressure Elevation

Impaired aqueous egress raises intraocular pressure in the first weeks to months of life. The pressure itself is the same stressor as in the module's conserved chain, but its consequences differ because it is applied to an immature eye: it acts both on the optic nerve head, driving retinal ganglion cell loss, and on the still-distensible coats of the globe, which the adult eye cannot do. The two downstream branches from this node -- neurodegenerative and biomechanical -- are what make congenital glaucoma clinically distinct.

Anterior Chamber of Eyeball UBERON:0001766

Downstream

Distensible Globe Expansion

Retinal Ganglion Cell Loss

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"Elevated IOP can consequently cause loss of retinal ganglion cells (RGCs) and a progressive optic neuropathy"

Establishes the causal link from raised intraocular pressure to retinal ganglion cell loss and progressive optic neuropathy in childhood glaucoma, the neurodegenerative branch from this node. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:20301314 SUPPORT Other

"Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep..."

The GeneReviews clinical characterisation places raised intraocular pressure at the head of a chain that includes both globe enlargement and optic atrophy, matching the two downstream branches asserted here. Evidence source is OTHER because GeneReviews is an expert-curated clinical synthesis rather than a primary study.

Distensible Globe Expansion

The branch that has no counterpart in the glaucoma_optic_neuropathy module, because it depends on a property of the infant eye rather than on the pressure itself. Before about three years of age the sclera and cornea are still elastic, so sustained ocular hypertension stretches them: the globe enlarges (buphthalmos), the corneal diameter increases beyond roughly 12 mm (megalocornea), the anterior sclera thins, and the axial elongation produces a progressive myopic shift. This node covers the biomechanical stretch alone; the corneal consequences of that stretch are the separate downstream node, because they are a distinct event with a distinct location and are what makes the eye cloudy rather than merely large.

Cornea UBERON:0000964 Sclera UBERON:0001773

Downstream

Descemet Membrane Rupture and Corneal Decompensation Stretching of the enlarging cornea tears Descemet membrane, which is what converts a large eye into an opaque one.

Deprivation and Refractive Amblyopia Axial elongation produces the progressive myopic shift that drives the refractive component of the amblyopia.

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"

Ties buphthalmos, increased corneal diameter and progressive myopia directly to raised intraocular pressure, and states the under-three-years age dependence this node's mechanism rests on. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:39941238 SUPPORT Other

"They present very specific ocular characteristics, such as buphthalmos or progressive myopic shift, corneal modifications such as Haab striae, corneal edema or increased corneal diameter"

Independently confirms buphthalmos, progressive myopic shift and increased corneal diameter as characteristic of childhood glaucoma. Evidence source is OTHER because this is citation-bearing review prose rather than the paper's own study result.

Descemet Membrane Rupture and Corneal Decompensation

Stretching of the cornea tears Descemet membrane, producing the curvilinear Haab striae, and breaches of that endothelial barrier allow aqueous into the stroma, causing the corneal edema and opacification that make the eye cloudy. The same corneal irritation drives the classic presenting triad of epiphora, photophobia and blepharospasm. This node is why congenital glaucoma is recognised by inspection of the eye in infancy rather than by perimetry.

Cornea UBERON:0000964

Downstream

Deprivation and Refractive Amblyopia Corneal oedema and opacification obscure the visual axis, driving the deprivation component of the amblyopia.

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"

Names Haab striae and corneal oedema among the consequences of raised intraocular pressure, which are the two findings this node asserts. Evidence source is OTHER because this statement is citation-bearing review prose rather than the paper's own study result.

PMID:20301314 SUPPORT Human Clinical

"Symptoms include photophobia, blepharospasm, and excessive tearing. Typically, the diagnosis is made in the first year of life."

Documents the corneal irritation triad this node produces, and its presentation in the first year of life.

Retinal Ganglion Cell Loss

Pressure-related injury at the optic nerve head causes retinal ganglion cell loss, the conserved effector step of every glaucoma. This node is confined to the cell-level loss so that it matches the module anchor it declares; the optic nerve head changes it produces, and the reversibility that distinguishes infant from adult disease, are the separate downstream node. Whatever ganglion cell loss has occurred is irreversible.

Retinal Ganglion Cell CL:0000740

Neuron Apoptotic Process GO:0051402 ↑ INCREASED

Optic Disc UBERON:0001783

Downstream

Optic Nerve Head Degeneration and Glaucomatous Cupping Ganglion cell axon loss remodels the optic nerve head, producing the glaucomatous cupping seen on examination.

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Elevated IOP can consequently cause loss of retinal ganglion cells (RGCs) and a progressive optic neuropathy"

States the retinal-ganglion-cell-loss step this node conforms to in the glaucoma_optic_neuropathy module, in the childhood-glaucoma context. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Optic Nerve Head Degeneration and Glaucomatous Cupping

Loss of ganglion cell axons remodels the optic nerve head into the glaucomatous cup. Congenital disease qualifies this step in one important way: optic disc cupping in an infant is partially reversible once intraocular pressure is controlled, which is not true of established adult cupping. Reversal reflects recovery of the compliant immature lamina cribrosa rather than regrowth of lost axons, so a reversing cup is evidence of pressure control and must NOT be read as recovered ganglion cells. This node exists separately from the ganglion cell node precisely so that the reversible tissue change and the irreversible cell loss are not conflated.

Optic Disc UBERON:0001783

Downstream

Childhood Visual Impairment and Blindness Established optic neuropathy is the irreversible route to childhood visual loss, alongside the amblyopic route.

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"however optic disc cupping can be reversible with treatment"

Supports the qualification that distinguishes the congenital form from adult glaucoma: infant disc cupping can reverse with pressure control. Evidence source is OTHER because this statement is citation-bearing review prose rather than the paper's own study result.

Deprivation and Refractive Amblyopia

A second, non-glaucomatous route to permanent vision loss that is specific to disease onset during the critical period of visual development. Corneal opacification degrades the retinal image (deprivation), and the axial elongation of an enlarging globe -- often asymmetric between the two eyes -- produces high myopia and anisometropia (refractive). Either can prevent normal cortical visual development even after intraocular pressure is fully controlled and the optic nerve is spared, which is why management of congenital glaucoma is not complete when pressure is normalised: refractive correction and amblyopia therapy are required in parallel.

Downstream

Childhood Visual Impairment and Blindness

Show evidence (2 references)

PMID:38249492 SUPPORT Other

"Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."

Establishes both the refractive component and the requirement for explicit amblyopia therapy during early visual development, which is the claim this node makes. Evidence source is OTHER because this is an expert clinical perspective article.

PMID:38755526 SUPPORT Other

"Prognosis and management of CG relies principally on prompt, precise diagnosis, and effective control of the IOP and prevention of amblyopia to preserve visual function"

Places prevention of amblyopia alongside pressure control as a determinant of visual outcome, supporting this node as a parallel rather than subordinate route to vision loss. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Childhood Visual Impairment and Blindness

The clinical endpoint, reached by two converging routes -- irreversible ganglion cell and axon loss, and amblyopia from deprivation and anisometropia. Childhood glaucoma accounts for roughly 5% of childhood blindness worldwide. The outcome is not fixed: with prompt diagnosis and effective pressure control the disease is frequently stationary and useful vision is retained, so the endpoint here is contingent on treatment timing rather than an inevitable consequence of the genotype.

Retinal Ganglion Cell CL:0000740

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"Childhood glaucoma (CG) encompasses a heterogeneous group of genetic eye disorders that is responsible for approximately 5% of childhood blindness worldwide."

Quantifies the contribution of childhood glaucoma to childhood blindness, the population-level statement of this consequence node. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:39941238 SUPPORT Other

"with appropriate management, the prognosis of PCG may be quite favorable: stationary disease has been reported in 90.3% of cases after one year, with a median visual acuity in the better eye of 20/30."

Supports the contingency asserted in the description -- the endpoint is strongly modified by timely management. Evidence source is OTHER because this is a clinical review summarising reported outcomes.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

13

Eye 5

Corneal Opacity and Edema HP:0007957

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep..."

Names corneal edema and opacification as characteristic features, linked to the Descemet membrane rupture described here. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Epiphora HP:0009926

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"

Names epiphora as a common presenting feature of childhood glaucoma. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Photophobia HP:0000613

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"

Names photophobia as a common presenting feature of childhood glaucoma. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Progressive Myopia HP:0000545

Course: PROGRESSIVE

Show evidence (2 references)

PMID:38755526 SUPPORT Other

"Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"

Names progressive myopia as a consequence of raised intraocular pressure in this disease, supporting the PROGRESSIVE clinical course qualifier. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

PMID:38249492 SUPPORT Other

"Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."

Confirms myopia is common in this population and links it to the need for refractive correction. Evidence source is OTHER because this is an expert clinical perspective article.

Visual Impairment HP:0000505

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"Depending on when treatment is instituted, visual acuity may be reduced and/or visual fields may be restricted. In untreated individuals, blindness invariably occurs."

States both the treatment-timing dependence and the untreated outcome recorded in the description. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Other 8

Buphthalmos HP:0000557

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"

Directly attributes buphthalmos to raised intraocular pressure with onset before three years, which is the age-dependence recorded in the description. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Megalocornea HP:0000485

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"

States increased corneal diameter with the conventional 12 mm threshold as a consequence of raised intraocular pressure in this disease. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Haab Striae HP:6001217

Show evidence (2 references)

PMID:39941238 SUPPORT Other

"They present very specific ocular characteristics, such as buphthalmos or progressive myopic shift, corneal modifications such as Haab striae, corneal edema or increased corneal diameter"

Lists Haab striae among the specific corneal findings of childhood glaucoma. Evidence source is OTHER because this is a clinical review.

PMID:20301314 SUPPORT Other

"Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep..."

Identifies Haab striae explicitly as rupture of Descemet membrane, the mechanism given in the description. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Blepharospasm HP:0000643

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"

Names blepharospasm as a common presenting feature of childhood glaucoma. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Ocular Hypertension HP:0007906

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"The diagnosis of PCG is based on clinical criteria including: elevated IOP in a child typically before age one year, enlargement of the globe, increased corneal diameter, cloudy corneas, breaks in Decsemet"

Places elevated intraocular pressure before age one at the head of the diagnostic criteria and shows it is assessed together with globe and corneal measures. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Deep Anterior Chamber HP:0007765

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep..."

Names an anomalously deep anterior chamber among the characteristic features. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Increased Cup-to-Disc Ratio HP:0012796

Show evidence (2 references)

PMID:39941238 SUPPORT Other

"optic nerve damage such as increased cup-disc ratio, cup-disc ratio asymmetry of at least 0.2 and focal rim thinning"

Specifies the optic nerve head findings, including the asymmetry threshold, used to recognise glaucomatous damage in childhood glaucoma. Evidence source is OTHER because this is a clinical review.

PMID:38755526 SUPPORT Other

"however optic disc cupping can be reversible with treatment"

Supports the qualification in the description that infant disc cupping can reverse with pressure control. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Iris Atrophy HP:0001089

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep..."

Names iris atrophy among the characteristic features of PCG. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

🧬

Genetic Associations

8

CYP1B1 (Causative)

Gene: CYP1B1 hgnc:2597 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

Show evidence (3 references)

PMID:9097971 SUPPORT Human Clinical

"The mutations detected in the affected members of these families were not present in 470 chromosomes from randomly selected normal individuals, thus strongly suggesting that CYP1B1 is the gene for the GLC3A locus on 2p21."

The original identification of CYP1B1 as the GLC3A gene, with control-panel exclusion of the variants.

PMID:9463332 SUPPORT Human Clinical

"Sequence analysis of the coding exons for cytochrome P4501B1 (CYP1B1) in these 25 families revealed three distinctive mutations that segregate with the phenotype in 24 families."

Independent confirmation of CYP1B1 as causative with segregation in 24 of 25 linked families.

PMID:38386645 SUPPORT Human Clinical

"CYP1B1 variants were associated with region and population-specific prevalence ranging from 5% to 86% among those with primary congenital glaucoma."

Quantifies the population dependence of the CYP1B1 contribution across 196 studies, which is the caveat recorded in the notes.

LTBP2 (Causative)

Gene: LTBP2 hgnc:6715 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Recessive

Show evidence (3 references)

PMID:19361779 SUPPORT Human Clinical

"Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."

Establishes LTBP2 null mutations as causative in the populations named in the notes.

PMID:19361779 SUPPORT Human Clinical

"LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG."

Records the authors' own explicit uncertainty about whether LTBP2 is the GLC3C gene. Marked PARTIAL because it supports the causal role while leaving the locus assignment open.

PMID:23218701 SUPPORT Human Clinical

"No disease-causing mutations within the LTBP2 and MYOC genes were discovered."

A negative result in a United States PCG cohort. Marked PARTIAL because it does not refute LTBP2 causality, established in consanguineous populations, but does bound its contribution in outbred cohorts.

TEK (Causative)

Gene: TEK hgnc:11724 relationship_type: CAUSATIVE variant_origin: GERMLINE

Autosomal Dominant

Show evidence (2 references)

PMID:27270174 SUPPORT In Vitro

"Multiple cellular mechanisms were responsible for the loss of protein function resulting from individual TEK variants, including an absence of normal protein production, protein aggregate formation, enhanced proteasomal degradation, altered subcellular localization, and reduced responsiveness to..."

Documents the several distinct cellular routes by which different TEK alleles converge on the same haploinsufficient endpoint.

PMID:38755526 SUPPORT Human Clinical

"We identified two novel likely pathogenic variants in the TEK gene, in addition to one novel pathogenic copy number variant (CNV) in FOXC1."

Independent replication of TEK as a childhood-glaucoma gene in a separate genomically characterised cohort.

ANGPT1 (Causative)

Gene: ANGPT1 hgnc:484 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (1 reference)

PMID:29106382 SUPPORT Human Clinical

"Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease."

Reports the functional demonstration of loss of function for the patient ANGPT1 alleles and the authors' causality claim.

FOXC1 (Causative)

Gene: FOXC1 hgnc:3800 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (2 references)

PMID:35882526 SUPPORT Human Clinical

"128 individuals with causative variants in PITX2 or FOXC1, including 81 new cases, were investigated. Ocular anomalies showed significant overlap but with broader variability and earlier onset of glaucoma for FOXC1-related ARS."

Establishes FOXC1 as causative in the largest reported ARS cohort and documents the earlier glaucoma onset that distinguishes it from PITX2.

PMID:12624268 SUPPORT Model Organism

"Tyr also modified the drainage structure dysgenesis in mice with a mutant Foxc1 gene, which is also involved in PCG."

Shows Foxc1 mutation produces modifiable drainage-structure dysgenesis in mice, linking this gene to the same developmental lesion as CYP1B1.

PITX2 (Causative)

Gene: PITX2 hgnc:9005 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (1 reference)

PMID:35882526 SUPPORT Human Clinical

"128 individuals with causative variants in PITX2 or FOXC1, including 81 new cases, were investigated. Ocular anomalies showed significant overlap but with broader variability and earlier onset of glaucoma for FOXC1-related ARS."

Establishes PITX2 as one of the two causative ARS genes in the largest reported cohort.

PAX6 (Causative)

Gene: PAX6 hgnc:8620 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (2 references)

PMID:39368260 SUPPORT Other

"Glaucoma remains, along with limbal insufficiency, one of the major causes of blindness in congenital aniridia."

Establishes the clinical weight of glaucoma within PAX6-related congenital aniridia. Evidence source is OTHER because this is a literature review.

PMID:41936534 SUPPORT Other

"Mutations in key transcriptional and structural genes-including PAX6, FOXC1, PITX2, CYP1B1, LTBP2, PXDN, and GJA8-account for the majority of ASD cases."

Places PAX6 with FOXC1 and PITX2 among the genes accounting for most anterior segment dysgenesis, the group curated under this subtype. Evidence source is OTHER because this is a systematic review.

SVEP1 (Candidate modifier of TEK-related penetrance and severity)

Gene: SVEP1 hgnc:15985 relationship_type: MODIFIER variant_origin: GERMLINE

Show evidence (1 reference)

PMID:38386645 SUPPORT Model Organism

"one study has proposed that the SVEP1 gene could be a potent genetic modifier as SVEP1 loss of function alleles were demonstrated to reduce TEK expression in vascular endothelial cells in animal models"

States the proposed modifier relationship and, importantly, its basis: loss-of-function alleles reducing TEK expression in animal models. supports is PARTIAL and evidence_source is MODEL_ORGANISM because the claim is a proposal grounded in model-organism expression data rather than a demonstrated human genotype-phenotype relationship.

💊

Medical Actions

5

Angle Surgery (Goniotomy or Trabeculotomy)

Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Incision of the dysgenetic trabecular meshwork to open a direct route from the anterior chamber into Schlemm canal. Goniotomy requires a clear cornea to visualise the angle; trabeculotomy ab externo does not, and is therefore preferred when the cornea is edematous, which is common at presentation in regions where disease is advanced at diagnosis. This is first-line surgery in primary congenital glaucoma and is mechanism-directed rather than symptomatic -- it addresses the dysgenetic meshwork itself. Note the corollary: where the angle is obliterated by adhesions rather than dysgenetic, as in some Peters anomaly eyes, angle incision is much less effective.

Mechanism Target:

BYPASSES Trabeculodysgenesis and Congenital Outflow Obstruction — Angle incision creates a direct outflow channel past the dysgenetic meshwork rather than restoring normal meshwork development.

Show evidence (1 reference)

PMID:39941238 SUPPORT Other

"Surgical intervention remains the cornerstone of treatment, and initial surgical options include angle surgeries such as goniotomy and trabeculotomy, aimed at improving aqueous outflow."

States that angle surgery acts by improving aqueous outflow, which is the mechanism node targeted here. Evidence source is OTHER because this is a clinical review.

Show evidence (4 references)

PMID:26886124 SUPPORT Other

"Angle surgery is usually the first-line treatment in the surgical management of primary congenital glaucoma because it has a relatively good success rate with a low complication rate."

Establishes angle surgery as first-line, with the risk-benefit reasoning. Evidence source is OTHER because this is a surgical review.

PMID:38249492 SUPPORT Other

"Angle incision surgery such as goniotomy or trabeculotomy ab externo is the preferred choice of surgery in the Caucasian population."

Supports angle incision as the preferred first operation, and flags the population qualification carried in the description. Evidence source is OTHER because this is an expert clinical perspective.

PMID:30846492 SUPPORT Human Clinical

"Trabeculotomy seems to be superior to goniotomy in primary congenital glaucoma."

Compares the two angle procedures in a 452-eye series and favours trabeculotomy, supporting the preference stated in the description.

+ 1 more reference

Filtering Surgery and Glaucoma Drainage Devices

Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Second-line surgery after failed angle incision: trabeculectomy, usually with an antifibrotic agent because the pediatric healing response scars a bleb aggressively, or implantation of a glaucoma drainage device. Both create an outflow route that bypasses the natural drainage pathway entirely rather than repairing it. Cyclodestructive procedures, which reduce aqueous production instead of improving egress, are reserved for eyes with poor visual potential.

Mechanism Target:

BYPASSES Congenital Intraocular Pressure Elevation — A filtering bleb or drainage tube lowers intraocular pressure by routing aqueous around the diseased angle altogether.

Show evidence (1 reference)

PMID:39941238 SUPPORT Other

"For refractory cases, trabeculectomy and glaucoma drainage devices (GDDs) serve as second-line therapies."

Positions these procedures as second-line pressure-lowering therapy, which is the mechanism node targeted. Evidence source is OTHER because this is a clinical review.

Show evidence (1 reference)

PMID:26886124 SUPPORT Other

"After failed angle surgery or in cases of secondary pediatric glaucoma, options such as trabeculectomy, glaucoma drainage devices, or cyclodestructive procedures can be considered"

Sets out the second-line sequence recorded in the description, including the place of cyclodestruction. Evidence source is OTHER because this is a surgical review.

Topical and Systemic IOP-Lowering Pharmacotherapy

Action: Pharmacotherapy NCIT:C15986

Medical therapy has a supportive rather than definitive role in congenital glaucoma -- the reverse of adult glaucoma practice. It is used to clear the cornea before surgery so the angle can be seen, and as an adjunct postoperatively when pressure control is incomplete. Safety caveat carried from GeneReviews: alpha-2 agonists must be avoided in infants because of the risk of apnea and bradycardia, and echothiophate should be stopped before surgery to prevent prolonged apnea.

Mechanism Target:

INHIBITS Congenital Intraocular Pressure Elevation — Reduces aqueous production or increases outflow to lower intraocular pressure pending or supplementing definitive surgery.

Show evidence (1 reference)

PMID:38249492 SUPPORT Other

"Medical therapy only serves as a supportive role, and surgical intervention remains the principal therapeutic modality."

States the supportive, pressure-directed role of medical therapy relative to surgery. Evidence source is OTHER because this is an expert clinical perspective.

Show evidence (3 references)

PMID:20301314 SUPPORT Other

"Agents/circumstances to avoid: Alpha-2 agonists because of risk for apnea and bradycardia."

The GeneReviews drug-safety warning reproduced in the description. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

PMID:20301314 SUPPORT Other

"Discontinuation of medications such as Phospholine Iodide® (echothiophate) before surgery to prevent prolonged apnea."

The second GeneReviews safety instruction reproduced in the description. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

PMID:38755526 SUPPORT Other

"Medical management with both topical and oral drugs can be used as a temporary modality or as an adjunct to surgery, but surgery remains the predominant treatment in order to control the IOP"

Independently confirms the temporary/adjunctive role of medical therapy in childhood glaucoma. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

Refractive Correction and Amblyopia Therapy

Action: rehabilitation Ontology label: Rehabilitation NCIT:C15315

Spectacles or contact lenses for the myopic and anisometropic shift, together with occlusion or other amblyopia therapy during the critical period. This is not supportive care around the glaucoma -- it treats a parallel, independently sufficient cause of permanent vision loss, and omitting it can leave a child with a normal-pressure eye and no useful vision. Low-vision rehabilitation is added where impairment is established.

Mechanism Target:

INHIBITS Deprivation and Refractive Amblyopia — Refractive correction removes the defocus and occlusion therapy counters the cortical suppression, addressing the amblyogenic branch directly rather than the pressure.

Show evidence (1 reference)

PMID:38249492 SUPPORT Other

"Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."

Prescribes both refractive correction and amblyopia therapy for exactly the mechanism node targeted. Evidence source is OTHER because this is an expert clinical perspective.

Show evidence (1 reference)

PMID:38249492 SUPPORT Other

"Low-vision rehabilitation services should be provided to children with vision impairment."

Supports the low-vision rehabilitation component of this treatment. Evidence source is OTHER because this is an expert clinical perspective.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counseling must be mode-specific, since recurrence risk is 25% for the recessive CYP1B1 and LTBP2 forms but 50% for dominant TEK-related disease. Where a familial variant is known, counseling is delivered alongside the cascade testing curated under diagnosis:, which is what changes the surveillance plan for an at-risk newborn.

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier."

Supports the recessive recurrence risk quoted in the description. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

🔬

Diagnosis

3

Confirmatory molecular genetic testing

Molecular testing confirms the diagnosis when clinical features are inconclusive: biallelic pathogenic variants in CYP1B1 or LTBP2, or a heterozygous pathogenic variant in TEK.

genetic testing NCIT:C15709

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"Identification of biallelic pathogenic variants in CYP1B1 or LTBP2 or identification of a heterozygous pathogenic variant in TEK confirms the diagnosis if clinical features are inconclusive."

States the confirmatory diagnostic role of molecular testing. Evidence source is OTHER because GeneReviews is an expert-curated synthesis rather than a primary study.

Cascade testing of at-risk siblings

Once a familial variant is known, at-risk newborns can be tested directly rather than subjected to repeated examinations under anaesthesia. This is surveillance triage rather than treatment, and is the practical reason molecular diagnosis changes management in this disease.

genetic testing NCIT:C15709

Show evidence (1 reference)

PMID:20301314 SUPPORT Other

"molecular genetic testing of at-risk sibs as soon as possible after birth in order to avoid repeated examinations under anesthesia in young children who do not have the pathogenic variant(s)."

Gives the sibling-surveillance benefit that makes cascade testing a diagnostic and surveillance act. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

Examination Under Anesthesia

The diagnostic act in congenital glaucoma is a full examination under general anaesthesia, because an infant cannot cooperate with tonometry, gonioscopy, corneal diameter measurement, axial length measurement, or disc examination while awake. The diagnosis rests on the combination -- elevated intraocular pressure, globe enlargement, increased corneal diameter, corneal clouding, Descemet membrane breaks, and an anomalously deep anterior chamber -- rather than on any single measurement, which matters because anaesthesia itself perturbs the pressure reading.

Show evidence (3 references)

PMID:38249492 SUPPORT Other

"A proper diagnostic evaluation under anesthesia is advisable for all children who do not cooperate for an office examination."

States the requirement for examination under anaesthesia. Evidence source is OTHER because this is an expert clinical perspective.

PMID:20301314 SUPPORT Other

"The diagnosis of PCG is based on clinical criteria including: elevated IOP in a child typically before age one year, enlargement of the globe, increased corneal diameter, cloudy corneas, breaks in Decsemet"

Enumerates the composite clinical criteria on which diagnosis rests. Evidence source is OTHER because GeneReviews is an expert-curated synthesis.

PMID:39941238 SUPPORT Other

"In a young child, cooperation is difficult to establish; therefore, the intraocular pressure may read falsely high"

Supports the caveat that a single pressure reading in an uncooperative child is unreliable, which is why the composite criteria are used. Evidence source is OTHER because this is a clinical review.

📊

Prevalence

3

Denmark, nationwide, births 1977-2016

Annual Incidence 4.8 per 100,000 1–9 per 100,000 PCG

Complete national ascertainment over 40 years, restricted to isolated angle dysgenesis and excluding glaucoma associated with other congenital abnormalities -- so this is a PCG rate, not a childhood-glaucoma rate.

Show evidence (1 reference)

PMID:31663689 SUPPORT Human Clinical

"Of 118 patients were identified, annual incidence of PCG was 4.8 per 100 000 live born."

Gives the nationwide Danish incidence figure recorded here.

Western countries

Point Prevalence 4.0 per 100,000 (1.5–10.0) 1–9 per 100,000 PCG

Reported as one in 10,000 to 68,000 people in Western countries; converted to cases per 100,000 (100000/68000 = 1.5 to 100000/10000 = 10.0), with the midpoint recorded as the point estimate.

Show evidence (1 reference)

PMID:39941238 SUPPORT Other

"Primary congenital glaucoma has a prevalence of one in 10,000-68,000 people in Western countries."

Source of the Western-country range converted here. Evidence source is OTHER because this is a clinical review.

Slovakian Roma

Birth Prevalence 80.0 per 100,000 >1 in 1,000 PCG

Reported as 1/1250 in this highly consanguineous founder population (100000/1250 = 80). The roughly 20-fold excess over Western rates is the clearest demonstration that the population-level burden of congenital glaucoma tracks consanguinity and founder CYP1B1 alleles.

Show evidence (1 reference)

PMID:38755526 SUPPORT Other

"in highly consanguineous populations such as in Slovakian Roma (1/1250)"

Gives the founder-population rate converted here and names consanguinity as the driver. Evidence source is OTHER because this statement is citation-bearing review prose in the paper's introduction rather than its own study result.

📊

Related Datasets

4

A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus) geo:GSE73263

domestic cat BULK RNA SEQ n=2

PMID:27149523

Naturally occurring feline primary congenital glaucoma segregating an LTBP2 mutation, from a breeding colony established for the trait -- directly the GLC3C/GLC3D mechanism curated here, in a spontaneous large-eye model rather than an engineered rodent one. Accession, title, organism, and sample count verified against NCBI E-utilities on 2026-08-20; the values are GEO's own.

Zebrafish Cyp1b1 knockout alters eye and brain metabolomic profiles, affecting ocular and neurobehavioral function geo:GSE272589

zebrafish BULK RNA SEQ n=40

PMID:39890032

Cyp1b1 loss-of-function zebrafish, explicitly framed by its authors around the unresolved role of CYP1B1 in primary congenital glaucoma -- relevant to the metabolic-route question recorded in the cyp1b1_expression_site discussion. Verified against NCBI E-utilities on 2026-08-20.

Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies geo:GSE168200

house mouse SINGLE CELL RNA SEQ n=3

PMID:34663817

Single-cell transcriptomes of the mouse iridocorneal angle using loss of Schlemm canal as the perturbation, with angiopoietin-1 signalling as the stated premise -- the cell-resolved counterpart of the ANGPT1/TEK node curated here. Verified against NCBI E-utilities on 2026-08-20.

Pitx2-associated early-onset glaucoma alters corneal innervation and sensory function in a sex-specific manner [RNA-Seq cornea] geo:GSE336875

house mouse BULK RNA SEQ n=20

Pitx2 mutant mouse cornea, described by its authors as a model of Pitx2-associated developmental glaucoma with anterior segment dysgenesis, ocular hypertension and optic neuropathy -- the ASD Congenital Glaucoma subtype curated here. No linked publication in GEO at the time of curation. Verified against NCBI E-utilities on 2026-08-20.

🔬

Clinical Trials

4

NCT04683289 NOT_APPLICABLE COMPLETED

Three-year randomized controlled study comparing visco-circumferential-suture-trabeculotomy with conventional trabeculotomy in primary congenital glaucoma (51 participants). Directly comparative for the angle-surgery treatment this entry curates as first-line.

Target Phenotypes: Ocular hypertension HP:0007906

Show evidence (1 reference)

clinicaltrials:NCT04683289 SUPPORT Human Clinical

"comparing outcomes of Visco-Circumferential-Suture-Trabeculotomy in primary congenital glaucoma to trabeculotomy"

Establishes the trial as a head-to-head comparison of two angle-surgery techniques in this disease.

NCT03541551 NOT_APPLICABLE COMPLETED

Randomized controlled study of Ologen collagen matrix as an adjuvant to combined trabeculectomy-trabeculotomy in primary congenital glaucoma (44 participants), testing whether reduced scarring improves bleb survival. Relevant to the filtering-surgery treatment, which this entry curates as the option used when angle surgery fails.

Target Phenotypes: Ocular hypertension HP:0007906

Show evidence (1 reference)

clinicaltrials:NCT03541551 SUPPORT Human Clinical

"the purpose of this study is to compare combined trabeculectomy with trabeculotomy (CTT) with adjuvant ologen® Collagen Matrix versus CTT without ologen® in children with PCG"

States the trial's comparison, which is why it is relevant to the filtering-surgery arm of this entry's treatment set.

NCT04116450 NOT_APPLICABLE COMPLETED

Prospective interventional study of circumferential trabeculotomy performed with an illuminated microcatheter in congenital glaucoma, with intraocular pressure as the primary endpoint and corneal diameter and cup-to-disc ratio as secondary endpoints -- the two stretch-related measures this entry treats as markers of the biomechanical branch.

Target Phenotypes: Ocular hypertension HP:0007906 Megalocornea HP:0000485

Show evidence (1 reference)

clinicaltrials:NCT04116450 SUPPORT Human Clinical

"This was a prorospective study of 25 eyes of 25 patients with primary congenital or juvenile glaucoma those underwent circumferential trabeculotomy done with an illuminated microcatheter through a period of 24 months."

Establishes the trial population and the angle-surgery intervention. The spelling of "prorospective" is the registry record's own.

NCT06189326 NOT_APPLICABLE UNKNOWN

Comparison of non-penetrating deep sclerectomy against combined trabeculotomy-trabeculectomy in primary congenital glaucoma. Relevant to this entry's treatment section because the non-penetrating approach leaves a trabeculo-descemetic membrane intact, trading some pressure reduction for protection against early postoperative hypotony in a small eye.

Target Phenotypes: Ocular hypertension HP:0007906

Show evidence (1 reference)

clinicaltrials:NCT06189326 SUPPORT Human Clinical

"The aim of this study is to assess the safety and efficacy outcomes of non-penetrating deep sclerectomy versus combined trabeculotomy-trabeculectomy in the treatment of congenital primary glaucoma"

States the trial's comparison of the two surgical approaches in this disease.

🐁

Animal Models

3

Cyp1b1-null mouse

Constitutive Cyp1b1 knockout producing ocular drainage-structure abnormalities that resemble those described in human primary congenital glaucoma. Also the system in which tyrosinase was identified as a modifier of the drainage phenotype.

Species

Mouse

Genotype

Cyp1b1-/-

Publication

PMID:12624268

Pathograph links

Trabeculodysgenesis and Congenital Outflow Obstruction recapitulates fidelity: moderate Reproduces the maldeveloped conventional outflow pathway that is the proximate lesion in CYP1B1-related disease.

Limitations: Drainage-structure dysgenesis is reported as resembling the human lesion rather than as measured intraocular hypertension in this work, and the phenotype is modifier-sensitive: severity depends on Tyr genotype, so the model's expressivity is strain-dependent rather than a fixed readout.

Show evidence (1 reference)

PMID:12624268 SUPPORT Model Organism

"Here we show that Cyp1b1-/- mice have ocular drainage structure abnormalities resembling those reported in human PCG patients."

States the recapitulation claim and its scope, in the authors' own hedged terms.

Angpt1-knockout mouse

Angiopoietin-ligand knockouts that fail to develop Schlemm canal normally. The double knockout lacks the canal entirely, showing that ANGPT2 compensates for ANGPT1 loss.

Species

Mouse

Genotype

Angpt1 knockout; Angpt1/Angpt2 double knockout

Publication

PMID:29106382

Pathograph links

Angiopoietin-TEK Signaling Insufficiency and Schlemm Canal Hypoplasia recapitulates fidelity: high Reproduces both halves of this node: a hypomorphic Schlemm canal and the resulting raised intraocular pressure.

Limitations: Models the ligand side of the axis, whereas the human disease curated here is caused by loss-of-function in the TEK receptor; the compensatory ANGPT2 relationship is demonstrated in mouse and is not established in humans.

Show evidence (1 reference)

PMID:29106382 SUPPORT Model Organism

"We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure."

Directly evidences the canal hypoplasia and the intraocular pressure elevation this node asserts.

Zebrafish cyp1b1 knockout

Zebrafish cyp1b1 knockout, the model behind the geo:GSE272589 dataset curated in this entry. It is included specifically because it does NOT reproduce the glaucoma phenotype, which is the structural counterpart of the cyp1b1_mouse_phenotype_fidelity discussion.

Species

Zebrafish

Genotype

cyp1b1 null

Publication

PMID:39890032

Pathograph links

Trabeculodysgenesis and Congenital Outflow Obstruction fails to recapitulate fidelity: low Adult mutant eye morphology, including the anterior chamber angle and cornea, is indistinguishable from wild type. The model is informative about CYP1B1 metabolic function but is not a phenocopy of congenital glaucoma, and must not be cited as evidence that CYP1B1 loss produces angle dysgenesis.

Limitations: Species divergence in the Cyp1 family is the authors' own proposed explanation: zebrafish carry Cyp1c and Cyp1d enzymes absent from mammals, so zebrafish Cyp1b1 may not parallel mammalian CYP1B1 function. The negative result therefore bounds what the zebrafish system can be used for rather than casting doubt on the human gene-disease relationship.

Show evidence (2 references)

PMID:39890032 SUPPORT Model Organism

"However, adult mutant eye morphology, including glaucoma related tissues like the anterior chamber angles and the cornea, was similar to the wildtype (WT)."

States plainly that the glaucoma-relevant ocular anatomy is unaffected in the knockout, which is what makes this a FAILS_TO_RECAPITULATE link rather than a partial one.

+ 1 more reference

{ }

Source YAML

click to show

name: Congenital Glaucoma
creation_date: "2026-08-20T00:00:00Z"
category: Mendelian
parents:
- Glaucoma
disease_term:
  preferred_term: congenital glaucoma
  term:
    id: MONDO:0020366
    label: congenital glaucoma
description: >-
  Congenital glaucoma is the developmental glaucoma of infancy and early
  childhood, arising from maldevelopment of the aqueous outflow apparatus rather
  than from its acquired degeneration. Neural-crest-derived periocular mesenchyme
  fails to remodel normally into a mature trabecular meshwork and Schlemm canal,
  so aqueous outflow resistance is abnormal from birth and intraocular pressure
  rises within the first weeks to months of life. Because the infant sclera and
  cornea are still distensible, the raised pressure does something it cannot do in
  an adult eye: it stretches the globe. This produces the features that define the
  entity clinically and separate it from every adult glaucoma -- buphthalmos,
  megalocornea, corneal edema with curvilinear breaks in Descemet membrane (Haab
  striae), and a progressive myopic shift -- alongside the classic irritative triad
  of epiphora, photophobia, and blepharospasm. Optic disc cupping in an infant is
  partially reversible once pressure is controlled, another point of divergence
  from adult disease. Corneal opacification and anisometropia during the critical
  period of visual development add a second, non-glaucomatous route to permanent
  vision loss through deprivation and refractive amblyopia, so management must
  address amblyopia as well as pressure. Angle surgery, not topical medication, is
  the primary therapy.

  This entry is the umbrella for the congenital-onset forms. It covers primary
  congenital glaucoma (PCG), the nonsyndromic Mendelian disease of the GLC3A-GLC3E
  loci (CYP1B1, LTBP2, TEK, ANGPT1), together with the secondary congenital
  glaucomas that accompany non-acquired anterior segment anomalies -- the
  Axenfeld-Rieger spectrum, Peters anomaly, and aniridia. It deliberately does not
  re-derive the generic trabecular-outflow to intraocular-pressure to retinal
  ganglion cell chain, which is factored into the glaucoma_optic_neuropathy
  mechanism module and referenced here by conforms_to; nor the adult and
  multifactorial content in Glaucoma.yaml; nor the 3-to-40-year juvenile-onset
  entity in Juvenile_Open_Angle_Glaucoma.yaml. The dysgenesis-bearing syndromes
  themselves are curated separately (Axenfeld-Rieger_syndrome.yaml,
  Peters_Plus_Syndrome.yaml); what this entry adds for those is the shared route by
  which their angle anomaly becomes congenital glaucoma.
notes: >-
  Scope note on nomenclature. MONDO:0020366 congenital glaucoma is an umbrella
  term with no OMIM xref and no single causal gene; it subsumes primary congenital
  glaucoma (MONDO:0000365) and the numbered GLC3A-GLC3E entities. It carries
  "primary congenital glaucoma" only as a NARROW synonym, so this entry is
  deliberately broader than PCG alone and includes the secondary congenital forms
  associated with non-acquired ocular anomalies, following the Childhood Glaucoma
  Research Network (CGRN) primary/secondary split. Where a cited source speaks
  specifically of PCG, the evidence explanation says so.
has_subtypes:
- name: PCG
  display_name: Primary Congenital Glaucoma (nonsyndromic)
  description: >-
    Isolated, nonsyndromic developmental glaucoma with onset from birth to age
    three, caused by an isolated dysgenesis of the trabecular meshwork and
    iridocorneal angle with no other ocular or systemic anomaly. This is the
    parent of the numbered GLC3 subtypes below and the most common childhood
    glaucoma. Inheritance is usually autosomal recessive with incomplete
    penetrance and a strong association with consanguinity, but the majority of
    cases worldwide are sporadic.
  classification: clinical_phenotype
  subtype_term:
    preferred_term: primary congenital glaucoma
    term:
      id: MONDO:0000365
      label: primary congenital glaucoma
  evidence:
  - reference: PMID:28549150
    reference_title: "Primary congenital and developmental glaucomas."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is isolated, non-syndromic glaucoma that occurs in the first three years of life and is a major cause of childhood blindness."
    explanation: >-
      Defines PCG as isolated, non-syndromic, and occurring in the first three
      years, which is the boundary this subtype draws against the secondary
      forms. Evidence source is OTHER because this is a genetics review.
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "PCG is considered the most common glaucoma in children, not associated with other syndromic manifestations. Usually, it is inherited in an autosomal recessive manner, with a positive family history in cases of consanguinity"
    explanation: >-
      Supports the non-syndromic definition and the recessive/consanguinity
      pattern recorded in this subtype. Evidence source is OTHER because this is
      a clinical review.
- name: GLC3A
  display_name: GLC3A - CYP1B1-related Primary Congenital Glaucoma
  description: >-
    Autosomal recessive PCG mapping to 2p21 and caused by biallelic CYP1B1
    variants. CYP1B1 is by far the most frequently implicated gene in congenital
    glaucoma worldwide, though its share of cases is strongly
    population-dependent, being highest in consanguineous and founder populations
    and much lower in outbred cohorts. Penetrance is incomplete and expressivity
    is variable, so mildly affected relatives of a proband can be missed.
  classification: molecular
  subtype_term:
    preferred_term: glaucoma 3A
    term:
      id: MONDO:0009277
      label: glaucoma 3A
  genes:
  - preferred_term: CYP1B1
    term:
      id: hgnc:2597
      label: CYP1B1
  evidence:
  - reference: PMID:9097971
    reference_title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mutations detected in the affected members of these families were not present in 470 chromosomes from randomly selected normal individuals, thus strongly suggesting that CYP1B1 is the gene for the GLC3A locus on 2p21."
    explanation: >-
      Establishes CYP1B1 as the GLC3A gene, which is the definition of this
      subtype.
  - reference: PMID:38386645
    reference_title: "Genetic changes and testing associated with childhood glaucoma: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CYP1B1 variants were associated with region and population-specific prevalence ranging from 5% to 86% among those with primary congenital glaucoma."
    explanation: >-
      Quantifies the population dependence of the CYP1B1 contribution asserted in
      this subtype description.
- name: GLC3B
  display_name: GLC3B - 1p36-linked Primary Congenital Glaucoma
  description: >-
    A second autosomal recessive PCG locus mapped by linkage to 1p36.2-36.1 in
    families unlinked to GLC3A. The GLC3B gene has still not been identified,
    which is why this subtype is defined by locus rather than by gene; the same
    linkage study also showed that families unlinked to both 2p21 and 1p36 exist,
    establishing further locus heterogeneity.
  classification: molecular
  subtype_term:
    preferred_term: glaucoma 3, primary infantile, B
    term:
      id: MONDO:0010968
      label: glaucoma 3, primary infantile, B
  evidence:
  - reference: PMID:8842741
    reference_title: "A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herein, we describe mapping of a new locus (designated GLC3B) for primary congenital glaucoma to the short arm of chromosome 1 (1p36.2-36.1)"
    explanation: >-
      The original mapping of GLC3B to 1p36, which is what defines this
      locus-based subtype.
  - reference: PMID:8842741
    reference_title: "A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the remaining four families are not linked to this part of chromosome 1, thus providing further evidence that at least one more locus for the autosomal recessive form of GLC3 must exist in the genome."
    explanation: >-
      Supports the further locus heterogeneity noted in this subtype's
      description.
- name: GLC3C
  display_name: GLC3C - 14q24-linked Primary Congenital Glaucoma
  description: >-
    A third autosomal recessive PCG locus on 14q24. LTBP2, which lies about 1.3 Mb
    proximal to the documented GLC3C interval, harbours null mutations that cause
    PCG; whether LTBP2 is the GLC3C gene itself or an adjacent second gene at the
    locus was left unresolved by the original report and is recorded here as an
    open question rather than a settled equivalence.
  classification: molecular
  subtype_term:
    preferred_term: glaucoma 3, primary congenital, C
    term:
      id: MONDO:0013121
      label: glaucoma 3, primary congenital, C
  evidence:
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG."
    explanation: >-
      States the unresolved relationship between LTBP2 and the GLC3C locus that
      is the reason this subtype is kept separate from GLC3D.
- name: GLC3D
  display_name: GLC3D - LTBP2-related Primary Congenital Glaucoma
  description: >-
    Autosomal recessive PCG caused by biallelic null mutations in LTBP2 at
    14q24.3, reported in consanguineous Pakistani families and in patients of Roma
    ethnicity. LTBP2 is an extracellular matrix protein of the latent TGF-beta
    binding protein family with homology to the fibrillins; its loss appears to be
    a structural rather than a signalling defect of the anterior segment.
  classification: molecular
  subtype_term:
    preferred_term: glaucoma 3, primary congenital, D
    term:
      id: MONDO:0013122
      label: glaucoma 3, primary congenital, D
  genes:
  - preferred_term: LTBP2
    term:
      id: hgnc:6715
      label: LTBP2
  evidence:
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."
    explanation: >-
      Establishes biallelic LTBP2 null mutations as the cause of this subtype in
      the populations named.
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "LTBP2 is the largest member of the latent transforming growth factor (TGF)-beta binding protein family, which are extracellular matrix proteins with multidomain structure. It has homology to fibrillins and may have roles in cell adhesion and as a structural component of microfibrils."
    explanation: >-
      Supports the fibrillin-homology and microfibril description given for this
      subtype.
- name: GLC3E
  display_name: GLC3E - TEK-related Primary Congenital Glaucoma
  description: >-
    PCG caused by heterozygous loss-of-function variants in TEK (TIE2), the
    endothelial angiopoietin receptor. Unlike the other GLC3 subtypes this one is
    autosomal dominant, acting through haploinsufficiency with markedly variable
    expressivity, so an obligate carrier parent may be unaffected or only mildly
    affected. The lesion is vascular-developmental: the Schlemm canal, a hybrid
    vessel with lymphatic and venous features, fails to form properly.
  classification: molecular
  subtype_term:
    preferred_term: glaucoma 3, primary congenital, E
    term:
      id: MONDO:0014998
      label: glaucoma 3, primary congenital, E
  genes:
  - preferred_term: TEK
    term:
      id: hgnc:11724
      label: TEK
  evidence:
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."
    explanation: >-
      Establishes the dominant, variably expressive inheritance that separates
      this subtype from the other GLC3 loci.
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm's canal (SC) and the trabecular meshwork."
    explanation: >-
      Supports the anatomical premise of this subtype, that congenital glaucoma
      arises from developmental failure of Schlemm canal alongside the trabecular
      meshwork. Evidence source is OTHER because this is the paper's framing
      statement of established etiology rather than its own result.
- name: ANGPT1 PCG
  display_name: ANGPT1-related Primary Congenital Glaucoma
  description: >-
    PCG attributable to rare variants in ANGPT1, the principal ligand of the TEK
    receptor, identified in a small number of subjects within a large
    international PCG cohort. Mechanistically this is the ligand-side counterpart
    of GLC3E and converges on the same Schlemm canal developmental defect;
    ANGPT2 is dispensable on its own but compensates for ANGPT1 loss, which is
    consistent with the rarity of ANGPT1-only disease. No separate numbered GLC3
    locus or MONDO subtype term has been assigned.
  classification: molecular
  genes:
  - preferred_term: ANGPT1
    term:
      id: hgnc:484
      label: ANGPT1
  evidence:
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients."
    explanation: >-
      Gives the human genetic basis and the rarity of this subtype.
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1"
    explanation: >-
      Supports the ligand-redundancy explanation this subtype gives for its own
      rarity.
- name: ASD Congenital Glaucoma
  display_name: Congenital Glaucoma Secondary to Non-Acquired Anterior Segment Dysgenesis
  description: >-
    Congenital and infantile glaucoma occurring as a complication of a
    non-acquired ocular anomaly of the anterior segment -- principally the
    Axenfeld-Rieger spectrum (PITX2, FOXC1), Peters anomaly (PAX6, FOXC1, PITX2,
    CYP1B1, B3GLCT and others), and PAX6-related aniridia. In the CGRN scheme
    these are secondary rather than primary childhood glaucomas, and in
    genomically characterised childhood-glaucoma cohorts they outnumber PCG. The
    underlying syndromes have their own dismech entries
    (Axenfeld-Rieger_syndrome, Peters_Plus_Syndrome); this subtype exists to hold
    the shared route by which their angle anomaly becomes congenital glaucoma,
    and the mechanism is not always the same as in PCG -- adhesional angle
    closure can operate alongside, or instead of, trabeculodysgenesis.
  classification: clinical_phenotype
  genes:
  - preferred_term: FOXC1
    term:
      id: hgnc:3800
      label: FOXC1
  - preferred_term: PITX2
    term:
      id: hgnc:9005
      label: PITX2
  - preferred_term: PAX6
    term:
      id: hgnc:8620
      label: PAX6
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "whereases secondary childhood glaucomas include those associated with non-acquired ocular anomalies (such as Axenfeld-Rieger spectrum (ARS), aniridia, and Peters anomaly)"
    explanation: >-
      Establishes the CGRN secondary category and names the three anomalies this
      subtype covers.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Twenty-five percent (5/20) of the solved families had primary congenital glaucoma (PCG), while 75% (15/20) had secondary CG"
    explanation: >-
      Supports the claim that secondary forms outnumber PCG in a genomically
      characterised childhood-glaucoma cohort.
pathophysiology:
- name: Neural Crest-Derived Periocular Mesenchyme Maldevelopment
  conforms_to: "anterior_segment_dysgenesis#Disrupted Periocular Mesenchyme Migration and Differentiation"
  role: trigger
  biological_scale: CELLULAR
  description: >-
    The trabecular meshwork, corneal endothelium and stroma, iris stroma, and
    ciliary body all derive from cranial neural crest cells that migrate around
    the optic cup as periocular mesenchyme. Congenital glaucoma is at root a
    neurocristopathy of that migration and differentiation programme: when the
    periocular mesenchyme fails to remodel normally into the drainage apparatus,
    the outflow structures are abnormal from the outset rather than degenerating
    later. This is the common developmental origin shared by primary congenital
    glaucoma and the anterior segment dysgenesis syndromes, and it explains why
    the same transcription factors (FOXC1, PITX2, PAX6) recur across both.
  locations:
  - preferred_term: Periocular Mesenchyme
    term:
      id: UBERON:0004017
      label: periocular mesenchyme
  - preferred_term: Iridocorneal Angle
    term:
      id: UBERON:0006206
      label: iridocorneal angle
  cell_types:
  - preferred_term: Migratory Cranial Neural Crest Cell
    term:
      id: CL:0000008
      label: migratory cranial neural crest cell
  biological_processes:
  - preferred_term: Neural Crest Cell Migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: ABNORMAL
  - preferred_term: Trabecular Meshwork Development
    term:
      id: GO:0002930
      label: trabecular meshwork development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:26043871
    reference_title: "Neural crest derivatives in ocular development: discerning the eye of the storm."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Indeed, abnormalities in neural crest development cause craniofacial defects and ocular anomalies, such as Axenfeld-Rieger syndrome and primary congenital glaucoma."
    explanation: >-
      Establishes defective neural crest development as the shared developmental
      origin of both primary congenital glaucoma and the anterior segment
      dysgenesis syndromes, which is the claim this trigger node makes. Evidence
      source is OTHER because this is a developmental-biology review.
  - reference: PMID:26043871
    reference_title: "Neural crest derivatives in ocular development: discerning the eye of the storm."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "These cells give rise to portions of the corneal endothelium and stroma, iris stroma, ciliary body stroma and muscles, sclera, and trabecular meshwork of the eye"
    explanation: >-
      Confirms that the trabecular meshwork and the other anterior segment
      structures affected in congenital glaucoma are neural crest derivatives,
      grounding the cell-type annotation on this node. Evidence source is OTHER
      because this is a review.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Defects in the TM and the iridocorneal angle of the anterior chamber, caused by maldevelopment of neural crest tissues, can hinder the drainage process leading to fluid accumulation in the anterior chamber with resultant raised IOP"
    explanation: >-
      States the causal step from neural crest maldevelopment to obstructed
      drainage and raised intraocular pressure, linking this trigger to the
      downstream outflow node.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:41936534
    reference_title: "Integrating clinical and genetic insights in anterior segment dysgenesis with glaucoma: A contemporary review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Anterior Segment Dysgenesis (ASD) encompasses a heterogeneous group of congenital ocular malformations resulting from disrupted differentiation of neural crest-derived tissues. These disorders frequently lead to developmental glaucoma, a major cause of childhood blindness."
    explanation: >-
      Attributes anterior segment dysgenesis specifically to disrupted
      differentiation of neural-crest-derived tissue and connects it to
      developmental glaucoma. Evidence source is OTHER because this is a
      systematic literature review.
  downstream:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
  - target: Secondary Angle Obstruction in Anterior Segment Dysgenesis
- name: CYP1B1 Deficiency in the Developing Anterior Segment
  conforms_to: "anterior_segment_dysgenesis#Anterior Segment Developmental Regulator Defect"
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    Biallelic loss-of-function variants in CYP1B1, a cytochrome P450
    monooxygenase at the GLC3A locus on 2p21, are the single most common
    molecular cause of congenital glaucoma. The reported mutations are frameshift
    and other null alleles predicted to remove domains essential for enzyme
    function, so the mechanism is loss of a metabolic activity rather than a toxic
    gain of function -- which distinguishes CYP1B1 disease from the misfolding
    MYOC mechanism of juvenile open-angle glaucoma. How that metabolic loss
    translates into dysgenesis is not settled; the leading proposal is that
    CYP1B1 generates or clears a diffusible retinoid or other oxygenated
    signalling molecule required for the proliferation and differentiation of the
    developing anterior segment. Cyp1b1-null mice reproduce the human drainage
    structure abnormalities, and the severity of that phenotype is modified by
    tyrosinase, indicating that CYP1B1 acts within a modifiable pathway rather
    than as a deterministic switch -- consistent with the incomplete penetrance
    and variable expressivity seen in human families.
  locations:
  - preferred_term: Anterior Chamber of Eyeball
    term:
      id: UBERON:0001766
      label: anterior chamber of eyeball
  molecular_functions:
  - preferred_term: Monooxygenase Activity
    term:
      id: GO:0004497
      label: monooxygenase activity
    modifier: LOSS_OF_FUNCTION
  biological_processes:
  - preferred_term: Retinoid Metabolic Process
    term:
      id: GO:0001523
      label: retinoid metabolic process
    modifier: DECREASED
  genetic_context:
    gene:
      preferred_term: CYP1B1
      term:
        id: hgnc:2597
        label: CYP1B1
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HOMOZYGOUS
  evidence:
  - reference: PMID:9097971
    reference_title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All of these are frameshift mutations that are predicted to remove domains essential for the function of the CYP1B1 protein."
    explanation: >-
      Establishes that the founding CYP1B1 congenital-glaucoma alleles are
      predicted functional nulls, supporting the loss-of-function
      functional_impact_category recorded on this node.
  - reference: PMID:9097971
    reference_title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CYP1B1 gene has previously been mapped within the GLC3A candidate region and its expression in the trabecular meshwork cells has been demonstrated in this study."
    explanation: >-
      Reports CYP1B1 expression in trabecular meshwork cells, which would place
      the enzyme in the affected tissue. Marked PARTIAL because later work
      disputes trabecular expression; see the KNOWLEDGE_GAP discussion
      cyp1b1_expression_site.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "CYP1B1 has also been implicated in both vitamin A metabolism and transcription induction of genes necessary for the proliferation and differentiation of multiple ocular elements"
    explanation: >-
      Supports the proposed metabolic/retinoid route by which CYP1B1 loss
      disturbs anterior segment proliferation and differentiation. Evidence
      source is OTHER because this statement is from the paper's review-style
      introduction rather than its own cohort data.
  - reference: PMID:12624268
    reference_title: "Modification of ocular defects in mouse developmental glaucoma models by tyrosinase."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here we show that Cyp1b1-/- mice have ocular drainage structure abnormalities resembling those reported in human PCG patients."
    explanation: >-
      Shows that CYP1B1 loss is sufficient to produce drainage-structure
      dysgenesis in a mammalian model, supporting the causal direction asserted
      by this node.
  - reference: PMID:12624268
    reference_title: "Modification of ocular defects in mouse developmental glaucoma models by tyrosinase."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Using Cyp1b1-/- mice, we identified the tyrosinase gene (Tyr) as a modifier of the drainage structure phenotype, with Tyr deficiency increasing the magnitude of dysgenesis."
    explanation: >-
      Demonstrates genetic modification of the CYP1B1 dysgenesis phenotype,
      supporting the description's claim that CYP1B1 acts within a modifiable
      pathway rather than deterministically.
  - reference: PMID:9463332
    reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional clinical and molecular data on some mildly affected relatives showed variable expressivity of PCG in this population."
    explanation: >-
      Documents variable expressivity among CYP1B1-linked relatives in the
      original Saudi linkage cohort, the human counterpart of the modifier effect
      seen in mice.
  downstream:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
- name: Angiopoietin-TEK Signaling Insufficiency and Schlemm Canal Hypoplasia
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    A mechanistically distinct route to the same outflow failure runs through the
    vascular development of Schlemm canal rather than through the trabecular
    mesenchyme. Schlemm canal is a hybrid vessel with lymphatic and venous
    features, and its formation depends on angiopoietin ligand signalling through
    the endothelial receptor tyrosine kinase TEK (TIE2). Heterozygous TEK
    loss-of-function variants cause congenital glaucoma by haploinsufficiency,
    with several different cellular routes to that shared endpoint -- absent
    protein production, aggregation, accelerated proteasomal degradation,
    mislocalisation, and blunted ligand responsiveness. Rare variants in the
    ligand ANGPT1 act on the same axis from the other side. Because the defect is
    gene-dosage-sensitive rather than all-or-none, expressivity is variable and
    inheritance is autosomal dominant, unlike the recessive CYP1B1 and LTBP2
    routes.
  locations:
  - preferred_term: Canal of Schlemm
    term:
      id: UBERON:0004029
      label: canal of Schlemm
  cell_types:
  - preferred_term: Schlemm's Canal Endothelial Cell
    term:
      id: CL:4033097
      label: Schlemm's canal endothelial cell
  biological_processes:
  - preferred_term: Tie Signaling Pathway
    term:
      id: GO:0048014
      label: Tie signaling pathway
    modifier: DECREASED
  - preferred_term: Vasculature Development
    term:
      id: GO:0001944
      label: vasculature development
    modifier: ABNORMAL
  genetic_context:
    gene:
      preferred_term: TEK
      term:
        id: hgnc:11724
        label: TEK
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
  evidence:
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function."
    explanation: >-
      Establishes TEK haploinsufficiency as a cause of congenital glaucoma in a
      substantial human cohort, the human anchor for this node.
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "hemizygosity for Tek led to the formation of severely hypomorphic Schlemm's canal and trabecular meshwork, as well as elevated IOP, demonstrating that anterior chamber vascular development is sensitive to Tek gene dosage"
    explanation: >-
      Demonstrates in mice that Tek gene dosage controls Schlemm canal and
      trabecular meshwork formation and intraocular pressure, supporting the
      dosage-sensitivity claim in the description.
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."
    explanation: >-
      Supports the autosomal dominant, variably expressive inheritance recorded
      for the GLC3E subtype, in contrast with the recessive CYP1B1/LTBP2 routes.
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure."
    explanation: >-
      Extends the mechanism to the ligand side of the axis, showing ANGPT1 loss
      alone produces a hypomorphic Schlemm canal and raised intraocular pressure.
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients."
    explanation: >-
      Provides the human genetic evidence for the ANGPT1 arm and quantifies its
      rarity relative to the cohort size.
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1"
    explanation: >-
      Documents ligand redundancy on this axis, which is the mechanistic reason
      ANGPT1-only disease is rare in human cohorts.
  downstream:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
- name: LTBP2 Loss and Anterior Segment Microfibril Deficiency
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    LTBP2, the largest member of the latent TGF-beta binding protein family, is an
    extracellular matrix protein with homology to the fibrillins and a probable
    role as a structural component of microfibrils. Biallelic null mutations cause
    congenital glaucoma in consanguineous Pakistani and Roma families. LTBP2
    localises to the anterior segment at the ciliary body and particularly the
    ciliary process, and the proposal is that its loss compromises the structural
    integrity of the anterior chamber and ciliary muscle tone rather than
    disturbing a signalling cascade -- making this an extracellular-matrix route
    to outflow failure, mechanistically parallel to but separate from the
    metabolic (CYP1B1) and vascular (TEK/ANGPT1) routes.
  locations:
  - preferred_term: Anterior Chamber of Eyeball
    term:
      id: UBERON:0001766
      label: anterior chamber of eyeball
  biological_processes:
  - preferred_term: Extracellular Matrix Organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
    modifier: ABNORMAL
  genetic_context:
    gene:
      preferred_term: LTBP2
      term:
        id: hgnc:6715
        label: LTBP2
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HOMOZYGOUS
  evidence:
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."
    explanation: >-
      Establishes biallelic LTBP2 null mutations as a cause of congenital
      glaucoma, the human genetic basis of this node.
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We confirmed localization of LTBP2 in the anterior segment of the eye, at the ciliary body, and particularly the ciliary process."
    explanation: >-
      Places the LTBP2 protein in the anterior segment tissue affected in
      congenital glaucoma, supporting the anatomical annotation on this node.
      Evidence source is IN_VITRO because this is a tissue localisation
      experiment.
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These findings reveal that LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone."
    explanation: >-
      States the proposed structural rather than signalling role for LTBP2 in
      anterior chamber development, as asserted in this node's description.
  downstream:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
- name: Trabeculodysgenesis and Congenital Outflow Obstruction
  conforms_to: "glaucoma_optic_neuropathy#Trabecular Meshwork Outflow Dysfunction"
  role: amplifier
  biological_scale: TISSUE
  description: >-
    The convergence point of the primary congenital routes. Instead of the
    acquired juxtacanalicular extracellular matrix accumulation and trabecular
    cell loss that raise outflow resistance in adult open-angle glaucoma, the
    congenital lesion is an angle that never matured: gonioscopy shows an immature
    appearance of arrested development, with a high flat iris insertion,
    peripheral scalloping, and circumferential iris vessels. Resistance to aqueous
    egress is therefore abnormal from birth. This node substitutes the
    disorder-specific developmental lesion into the module's conserved
    outflow-dysfunction step; the module's own trabecular-ECM-accumulation
    annotation is deliberately not copied here, because the mechanism is
    dysgenetic rather than degenerative.
  locations:
  - preferred_term: Eye Trabecular Meshwork
    term:
      id: UBERON:0005969
      label: eye trabecular meshwork
  - preferred_term: Iridocorneal Angle
    term:
      id: UBERON:0006206
      label: iridocorneal angle
  cell_types:
  - preferred_term: Trabecular Meshwork Cell
    term:
      id: CL:0002367
      label: trabecular meshwork cell
  biological_processes:
  - preferred_term: Trabecular Meshwork Development
    term:
      id: GO:0002930
      label: trabecular meshwork development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:9463332
    reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The autosomal recessive disorder primary congenital glaucoma (PCG) is caused by unknown developmental defect(s) of the trabecular meshwork and anterior chamber angle of the eye."
    explanation: >-
      Identifies a developmental defect of the trabecular meshwork and anterior
      chamber angle -- not an acquired degeneration -- as the causal lesion,
      which is the substitution this node makes into the module's
      outflow-dysfunction step.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Gonioscopy can reveal that the angle has an immature appearance of arrested development with a high flat iris insertion, with peripheral scalloping and circumferential iris vessels"
    explanation: >-
      Provides the direct clinical description of arrested angle development that
      distinguishes congenital trabeculodysgenesis from the adult trabecular
      lesion.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  downstream:
  - target: Congenital Intraocular Pressure Elevation
- name: Secondary Angle Obstruction in Anterior Segment Dysgenesis
  conforms_to: "glaucoma_optic_neuropathy#Trabecular Meshwork Outflow Dysfunction"
  role: amplifier
  biological_scale: TISSUE
  description: >-
    The parallel route taken by congenital glaucoma arising in a non-acquired
    anterior segment anomaly. Here outflow can fail by two mechanisms that are not
    interchangeable: trabeculodysgenesis of the kind seen in primary congenital
    glaucoma, and adhesional angle closure in which iridocorneal or
    lenticulocorneal adhesions physically obliterate the drainage angle. Which
    operates depends on the anomaly and its severity -- in Peters anomaly the risk
    of glaucoma rises steeply with the degree of anterior segment dysgenesis, from
    none in eyes with an isolated posterior corneal defect to the majority of eyes
    once lens abnormalities are present. In PAX6-related aniridia the mechanism
    remains genuinely unsettled, with congenital trabecular dysfunction,
    progressive angle closure, and postoperative ocular hypertension all
    proposed. This distinction matters therapeutically: angle incision surgery
    addresses a dysgenetic meshwork but not an obliterated angle.
  locations:
  - preferred_term: Iridocorneal Angle
    term:
      id: UBERON:0006206
      label: iridocorneal angle
  - preferred_term: Cornea
    term:
      id: UBERON:0000964
      label: cornea
  biological_processes:
  - preferred_term: Camera-Type Eye Development
    term:
      id: GO:0043010
      label: camera-type eye development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:37834882
    reference_title: "Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The pathogenesis of glaucoma secondary to Peters anomaly is thought to result from trabeculodysgenesis or angle closure mechanisms associated with iridocorneal and lenticulocorneal adhesions"
    explanation: >-
      States the two alternative mechanisms -- dysgenetic meshwork versus
      adhesional angle closure -- that this node asserts are not
      interchangeable.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:37834882
    reference_title: "Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Stage 1 Peters anomaly had no glaucoma, 52% of Stage 2 had glaucoma, and 75% of Stage 3 had glaucoma."
    explanation: >-
      Quantifies the dose-response between severity of anterior segment
      dysgenesis and glaucoma risk that this node's description asserts.
  - reference: PMID:39368260
    reference_title: "[Glaucoma in PAX6-related congenital aniridia: A review of the literature]."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "the advent of new anterior segment imaging techniques has allowed the identification of various potential mechanisms: congenital trabecular dysfunction, progressive closure of the iridocorneal angle, postoperative ocular hypertension."
    explanation: >-
      Documents that in PAX6-related congenital aniridia several competing
      mechanisms remain on the table, supporting the description's statement that
      the aniridia route is unsettled. Evidence source is OTHER because this is a
      literature review.
  - reference: PMID:35882526
    reference_title: "Axenfeld-Rieger syndrome: more than meets the eye."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ocular anomalies showed significant overlap but with broader variability and earlier onset of glaucoma for FOXC1-related ARS."
    explanation: >-
      Shows gene-specific variation in glaucoma onset within the Axenfeld-Rieger
      spectrum, supporting the claim that the secondary route is heterogeneous
      rather than a single stereotyped lesion.
  downstream:
  - target: Congenital Intraocular Pressure Elevation
- name: Congenital Intraocular Pressure Elevation
  conforms_to: "glaucoma_optic_neuropathy#Elevated Intraocular Pressure"
  role: amplifier
  biological_scale: ORGANISM
  description: >-
    Impaired aqueous egress raises intraocular pressure in the first weeks to
    months of life. The pressure itself is the same stressor as in the module's
    conserved chain, but its consequences differ because it is applied to an
    immature eye: it acts both on the optic nerve head, driving retinal ganglion
    cell loss, and on the still-distensible coats of the globe, which the adult
    eye cannot do. The two downstream branches from this node -- neurodegenerative
    and biomechanical -- are what make congenital glaucoma clinically distinct.
  locations:
  - preferred_term: Anterior Chamber of Eyeball
    term:
      id: UBERON:0001766
      label: anterior chamber of eyeball
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Elevated IOP can consequently cause loss of retinal ganglion cells (RGCs) and a progressive optic neuropathy"
    explanation: >-
      Establishes the causal link from raised intraocular pressure to retinal
      ganglion cell loss and progressive optic neuropathy in childhood glaucoma,
      the neurodegenerative branch from this node.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy."
    explanation: >-
      The GeneReviews clinical characterisation places raised intraocular
      pressure at the head of a chain that includes both globe enlargement and
      optic atrophy, matching the two downstream branches asserted here. Evidence
      source is OTHER because GeneReviews is an expert-curated clinical synthesis
      rather than a primary study.
  downstream:
  - target: Distensible Globe Expansion
  - target: Retinal Ganglion Cell Loss
- name: Distensible Globe Expansion
  role: effector
  biological_scale: TISSUE
  description: >-
    The branch that has no counterpart in the glaucoma_optic_neuropathy module,
    because it depends on a property of the infant eye rather than on the
    pressure itself. Before about three years of age the sclera and cornea are
    still elastic, so sustained ocular hypertension stretches them: the globe
    enlarges (buphthalmos), the corneal diameter increases beyond roughly 12 mm
    (megalocornea), the anterior sclera thins, and the axial elongation produces
    a progressive myopic shift. This node covers the biomechanical stretch
    alone; the corneal consequences of that stretch are the separate downstream
    node, because they are a distinct event with a distinct location and are
    what makes the eye cloudy rather than merely large.
  locations:
  - preferred_term: Cornea
    term:
      id: UBERON:0000964
      label: cornea
  - preferred_term: Sclera
    term:
      id: UBERON:0001773
      label: sclera
  evidence:
  - reference: PMID:38755526
    reference_title: Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia
    explanation: >-
      Ties buphthalmos, increased corneal diameter and progressive myopia
      directly to raised intraocular pressure, and states the under-three-years
      age dependence this node's mechanism rests on. Evidence source is OTHER
      because this statement is citation-bearing review prose in the paper's
      introduction rather than its own study result.
  - reference: PMID:39941238
    reference_title: Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: They present very specific ocular characteristics, such as buphthalmos or progressive myopic shift, corneal modifications such as Haab striae, corneal edema or increased corneal diameter
    explanation: >-
      Independently confirms buphthalmos, progressive myopic shift and increased
      corneal diameter as characteristic of childhood glaucoma. Evidence source
      is OTHER because this is citation-bearing review prose rather than the
      paper's own study result.
  downstream:
  - target: Descemet Membrane Rupture and Corneal Decompensation
    causal_link_type: DIRECT
    description: >-
      Stretching of the enlarging cornea tears Descemet membrane, which is what
      converts a large eye into an opaque one.
  - target: Deprivation and Refractive Amblyopia
    causal_link_type: DIRECT
    description: >-
      Axial elongation produces the progressive myopic shift that drives the
      refractive component of the amblyopia.
- name: Descemet Membrane Rupture and Corneal Decompensation
  role: effector
  biological_scale: TISSUE
  description: >-
    Stretching of the cornea tears Descemet membrane, producing the curvilinear
    Haab striae, and breaches of that endothelial barrier allow aqueous into the
    stroma, causing the corneal edema and opacification that make the eye
    cloudy. The same corneal irritation drives the classic presenting triad of
    epiphora, photophobia and blepharospasm. This node is why congenital
    glaucoma is recognised by inspection of the eye in infancy rather than by
    perimetry.
  locations:
  - preferred_term: Cornea
    term:
      id: UBERON:0000964
      label: cornea
  evidence:
  - reference: PMID:38755526
    reference_title: Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia
    explanation: >-
      Names Haab striae and corneal oedema among the consequences of raised
      intraocular pressure, which are the two findings this node asserts.
      Evidence source is OTHER because this statement is citation-bearing review
      prose rather than the paper's own study result.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Symptoms include photophobia, blepharospasm, and excessive tearing. Typically, the diagnosis is made in the first year of life.
    explanation: >-
      Documents the corneal irritation triad this node produces, and its
      presentation in the first year of life.
  downstream:
  - target: Deprivation and Refractive Amblyopia
    causal_link_type: DIRECT
    description: >-
      Corneal oedema and opacification obscure the visual axis, driving the
      deprivation component of the amblyopia.

- name: Retinal Ganglion Cell Loss
  conforms_to: glaucoma_optic_neuropathy#Retinal Ganglion Cell Apoptosis
  role: central_effector
  biological_scale: CELLULAR
  description: >-
    Pressure-related injury at the optic nerve head causes retinal ganglion cell
    loss, the conserved effector step of every glaucoma. This node is confined
    to the cell-level loss so that it matches the module anchor it declares;
    the optic nerve head changes it produces, and the reversibility that
    distinguishes infant from adult disease, are the separate downstream node.
    Whatever ganglion cell loss has occurred is irreversible.
  locations:
  - preferred_term: Optic Disc
    term:
      id: UBERON:0001783
      label: optic disc
  cell_types:
  - preferred_term: Retinal Ganglion Cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  biological_processes:
  - preferred_term: Neuron Apoptotic Process
    term:
      id: GO:0051402
      label: neuron apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:38755526
    reference_title: Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Elevated IOP can consequently cause loss of retinal ganglion cells (RGCs) and a progressive optic neuropathy
    explanation: >-
      States the retinal-ganglion-cell-loss step this node conforms to in the
      glaucoma_optic_neuropathy module, in the childhood-glaucoma context.
      Evidence source is OTHER because this statement is citation-bearing review
      prose in the paper's introduction rather than its own study result.
  downstream:
  - target: Optic Nerve Head Degeneration and Glaucomatous Cupping
    causal_link_type: DIRECT
    description: >-
      Ganglion cell axon loss remodels the optic nerve head, producing the
      glaucomatous cupping seen on examination.
- name: Optic Nerve Head Degeneration and Glaucomatous Cupping
  conforms_to: glaucoma_optic_neuropathy#Optic Nerve Degeneration and Neuroinflammation
  role: effector
  biological_scale: TISSUE
  description: >-
    Loss of ganglion cell axons remodels the optic nerve head into the
    glaucomatous cup. Congenital disease qualifies this step in one important
    way: optic disc cupping in an infant is partially reversible once
    intraocular pressure is controlled, which is not true of established adult
    cupping. Reversal reflects recovery of the compliant immature lamina
    cribrosa rather than regrowth of lost axons, so a reversing cup is evidence
    of pressure control and must NOT be read as recovered ganglion cells. This
    node exists separately from the ganglion cell node precisely so that the
    reversible tissue change and the irreversible cell loss are not conflated.
  locations:
  - preferred_term: Optic Disc
    term:
      id: UBERON:0001783
      label: optic disc
  evidence:
  - reference: PMID:38755526
    reference_title: Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: however optic disc cupping can be reversible with treatment
    explanation: >-
      Supports the qualification that distinguishes the congenital form from
      adult glaucoma: infant disc cupping can reverse with pressure control.
      Evidence source is OTHER because this statement is citation-bearing review
      prose rather than the paper's own study result.
  downstream:
  - target: Childhood Visual Impairment and Blindness
    causal_link_type: DIRECT
    description: >-
      Established optic neuropathy is the irreversible route to childhood visual
      loss, alongside the amblyopic route.

- name: Deprivation and Refractive Amblyopia
  role: effector
  biological_scale: ORGANISM
  description: >-
    A second, non-glaucomatous route to permanent vision loss that is specific to
    disease onset during the critical period of visual development. Corneal
    opacification degrades the retinal image (deprivation), and the axial
    elongation of an enlarging globe -- often asymmetric between the two eyes --
    produces high myopia and anisometropia (refractive). Either can prevent normal
    cortical visual development even after intraocular pressure is fully
    controlled and the optic nerve is spared, which is why management of
    congenital glaucoma is not complete when pressure is normalised: refractive
    correction and amblyopia therapy are required in parallel.
  evidence:
  - reference: PMID:38249492
    reference_title: "Approach to primary congenital glaucoma: A perspective."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."
    explanation: >-
      Establishes both the refractive component and the requirement for explicit
      amblyopia therapy during early visual development, which is the claim this
      node makes. Evidence source is OTHER because this is an expert clinical
      perspective article.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Prognosis and management of CG relies principally on prompt, precise diagnosis, and effective control of the IOP and prevention of amblyopia to preserve visual function"
    explanation: >-
      Places prevention of amblyopia alongside pressure control as a determinant
      of visual outcome, supporting this node as a parallel rather than
      subordinate route to vision loss.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  downstream:
  - target: Childhood Visual Impairment and Blindness
- name: Childhood Visual Impairment and Blindness
  conforms_to: "glaucoma_optic_neuropathy#Progressive Glaucomatous Optic Neuropathy"
  role: consequence
  biological_scale: ORGANISM
  description: >-
    The clinical endpoint, reached by two converging routes -- irreversible
    ganglion cell and axon loss, and amblyopia from deprivation and
    anisometropia. Childhood glaucoma accounts for roughly 5% of childhood
    blindness worldwide. The outcome is not fixed: with prompt diagnosis and
    effective pressure control the disease is frequently stationary and useful
    vision is retained, so the endpoint here is contingent on treatment timing
    rather than an inevitable consequence of the genotype.
  cell_types:
  - preferred_term: Retinal Ganglion Cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Childhood glaucoma (CG) encompasses a heterogeneous group of genetic eye disorders that is responsible for approximately 5% of childhood blindness worldwide."
    explanation: >-
      Quantifies the contribution of childhood glaucoma to childhood blindness,
      the population-level statement of this consequence node.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "with appropriate management, the prognosis of PCG may be quite favorable: stationary disease has been reported in 90.3% of cases after one year, with a median visual acuity in the better eye of 20/30."
    explanation: >-
      Supports the contingency asserted in the description -- the endpoint is
      strongly modified by timely management. Evidence source is OTHER because
      this is a clinical review summarising reported outcomes.
phenotypes:
- category: Ocular
  name: Buphthalmos
  description: >-
    Enlargement of the globe from stretching of the still-elastic infant sclera by
    sustained ocular hypertension. The defining sign of glaucoma with onset before
    about three years of age, and the feature that separates congenital from
    juvenile and adult glaucoma.
  phenotype_term:
    preferred_term: Buphthalmos
    term:
      id: HP:0000557
      label: Buphthalmos
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"
    explanation: >-
      Directly attributes buphthalmos to raised intraocular pressure with onset
      before three years, which is the age-dependence recorded in the
      description.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Megalocornea
  description: >-
    Increased corneal diameter, conventionally beyond about 12 mm in an infant,
    produced by pressure-driven corneal stretching rather than by a primary
    corneal size anomaly. Serial corneal diameter measurement under anaesthesia is
    a standard index of disease control.
  phenotype_term:
    preferred_term: Megalocornea
    term:
      id: HP:0000485
      label: Megalocornea
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"
    explanation: >-
      States increased corneal diameter with the conventional 12 mm threshold as
      a consequence of raised intraocular pressure in this disease.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Haab Striae
  description: >-
    Curvilinear horizontal breaks in Descemet membrane produced when the stretching
    cornea exceeds the elastic limit of that layer. They are pathognomonic of
    childhood pressure elevation and persist as a permanent record of it after
    pressure is controlled.
  phenotype_term:
    preferred_term: Haab striae
    term:
      id: HP:6001217
      label: Haab striae
  evidence:
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "They present very specific ocular characteristics, such as buphthalmos or progressive myopic shift, corneal modifications such as Haab striae, corneal edema or increased corneal diameter"
    explanation: >-
      Lists Haab striae among the specific corneal findings of childhood
      glaucoma. Evidence source is OTHER because this is a clinical review.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy."
    explanation: >-
      Identifies Haab striae explicitly as rupture of Descemet membrane, the
      mechanism given in the description. Evidence source is OTHER because
      GeneReviews is an expert-curated synthesis.
- category: Ocular
  name: Corneal Opacity and Edema
  description: >-
    Clouding of the cornea from stromal edema, following breaches of the corneal
    endothelial barrier as Descemet membrane tears. Beyond obscuring the view of
    the optic disc for the examiner, it degrades the retinal image during the
    critical period and is a direct cause of deprivation amblyopia.
  phenotype_term:
    preferred_term: Corneal opacity
    term:
      id: HP:0007957
      label: Corneal opacity
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy."
    explanation: >-
      Names corneal edema and opacification as characteristic features, linked to
      the Descemet membrane rupture described here. Evidence source is OTHER
      because GeneReviews is an expert-curated synthesis.
- category: Ocular
  name: Epiphora
  description: >-
    Excessive tearing, part of the classic irritative presenting triad. In an
    infant it is commonly first attributed to nasolacrimal duct obstruction, which
    is a recognised source of diagnostic delay.
  phenotype_term:
    preferred_term: Epiphora
    term:
      id: HP:0009926
      label: Epiphora
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"
    explanation: >-
      Names epiphora as a common presenting feature of childhood glaucoma.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Photophobia
  description: >-
    Light intolerance arising from corneal epithelial edema and irritation. With
    epiphora and blepharospasm it forms the triad that should prompt examination
    under anaesthesia in an infant.
  phenotype_term:
    preferred_term: Photophobia
    term:
      id: HP:0000613
      label: Photophobia
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"
    explanation: >-
      Names photophobia as a common presenting feature of childhood glaucoma.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Blepharospasm
  description: >-
    Reflex forced eyelid closure driven by corneal irritation, the third element
    of the presenting triad.
  phenotype_term:
    preferred_term: Blepharospasm
    term:
      id: HP:0000643
      label: Blepharospasm
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Childhood glaucoma commonly presents as bilateral disease with features of photophobia, epiphora and blepharospasm"
    explanation: >-
      Names blepharospasm as a common presenting feature of childhood glaucoma.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Ocular Hypertension
  description: >-
    Elevated intraocular pressure, the proximate stressor. Measurement in an
    infant is unreliable without general anaesthesia, and both anaesthetic agent
    and poor cooperation can bias the reading in either direction, so pressure is
    interpreted alongside corneal diameter, axial length, and disc appearance
    rather than alone.
  phenotype_term:
    preferred_term: Ocular hypertension
    term:
      id: HP:0007906
      label: Ocular hypertension
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The diagnosis of PCG is based on clinical criteria including: elevated IOP in a child typically before age one year, enlargement of the globe, increased corneal diameter, cloudy corneas, breaks in Decsemet"
    explanation: >-
      Places elevated intraocular pressure before age one at the head of the
      diagnostic criteria and shows it is assessed together with globe and
      corneal measures. Evidence source is OTHER because GeneReviews is an
      expert-curated synthesis.
- category: Ocular
  name: Deep Anterior Chamber
  description: >-
    Anomalously deep anterior chamber, a consequence of anterior segment
    enlargement under pressure. Useful in distinguishing congenital glaucoma from
    the shallow-chamber angle-closure mechanisms of adult disease.
  phenotype_term:
    preferred_term: Deep anterior chamber
    term:
      id: HP:0007765
      label: Deep anterior chamber
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy."
    explanation: >-
      Names an anomalously deep anterior chamber among the characteristic
      features. Evidence source is OTHER because GeneReviews is an expert-curated
      synthesis.
- category: Ocular
  name: Increased Cup-to-Disc Ratio
  description: >-
    Glaucomatous excavation of the optic nerve head, with interocular asymmetry
    and focal rim thinning as supporting signs. Unlike in adults, the cup can
    partially reverse once pressure is controlled, so a reduction is a marker of
    treatment response rather than of ganglion cell recovery.
  phenotype_term:
    preferred_term: Increased cup-to-disc ratio
    term:
      id: HP:0012796
      label: Increased cup-to-disc ratio
  evidence:
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "optic nerve damage such as increased cup-disc ratio, cup-disc ratio asymmetry of at least 0.2 and focal rim thinning"
    explanation: >-
      Specifies the optic nerve head findings, including the asymmetry threshold,
      used to recognise glaucomatous damage in childhood glaucoma. Evidence
      source is OTHER because this is a clinical review.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "however optic disc cupping can be reversible with treatment"
    explanation: >-
      Supports the qualification in the description that infant disc cupping can
      reverse with pressure control.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- category: Ocular
  name: Progressive Myopia
  description: >-
    Myopic shift driven by axial elongation of the stretching globe. Frequently
    asymmetric between eyes, producing the anisometropia that contributes to
    refractive amblyopia.
  phenotype_term:
    preferred_term: Myopia
    term:
      id: HP:0000545
      label: Myopia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Children with PCG develop buphthalmos if disease onset is before 3 years of age secondary to the raised intraocular pressure (IOP), increased corneal diameter (> 12 mm), Haab striae, corneal oedema, optic disc cupping and progressive myopia"
    explanation: >-
      Names progressive myopia as a consequence of raised intraocular pressure in
      this disease, supporting the PROGRESSIVE clinical course qualifier.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:38249492
    reference_title: "Approach to primary congenital glaucoma: A perspective."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."
    explanation: >-
      Confirms myopia is common in this population and links it to the need for
      refractive correction. Evidence source is OTHER because this is an expert
      clinical perspective article.
- category: Ocular
  name: Iris Atrophy
  description: >-
    Thinning of the iris stroma accompanying anterior segment stretching in
    long-standing disease.
  phenotype_term:
    preferred_term: Iris atrophy
    term:
      id: HP:0001089
      label: Iris atrophy
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma (PCG) is characterized by elevated intraocular pressure (IOP), enlargement of the globe (buphthalmos), edema, and opacification of the cornea with rupture of Descemet's membrane (Haab's striae), thinning of the anterior sclera and iris atrophy, anomalously deep anterior chamber, and structurally normal posterior segment except for progressive glaucomatous optic atrophy."
    explanation: >-
      Names iris atrophy among the characteristic features of PCG. Evidence
      source is OTHER because GeneReviews is an expert-curated synthesis.
- category: Ocular
  name: Visual Impairment
  description: >-
    Reduced visual acuity and restricted visual fields, reached through both
    ganglion cell loss and amblyopia. Severity depends heavily on how early
    treatment was instituted; untreated disease progresses to blindness.
  phenotype_term:
    preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Depending on when treatment is instituted, visual acuity may be reduced and/or visual fields may be restricted. In untreated individuals, blindness invariably occurs."
    explanation: >-
      States both the treatment-timing dependence and the untreated outcome
      recorded in the description. Evidence source is OTHER because GeneReviews
      is an expert-curated synthesis.
inheritance:
- name: Autosomal Recessive
  description: >-
    The usual pattern for primary congenital glaucoma, covering the CYP1B1
    (GLC3A) and LTBP2 (GLC3C/GLC3D) routes. Penetrance is incomplete and
    expressivity variable, so an obligate homozygote may be only mildly affected.
    Familial cases are strongly associated with consanguinity, but most cases
    worldwide are sporadic.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  penetrance: INCOMPLETE
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "PCG caused by biallelic pathogenic variants in CYP1B1 or LTBP2 is inherited in an autosomal recessive manner. PCG caused by a heterozygous pathogenic variant in TEK is inherited in an autosomal dominant manner."
    explanation: >-
      States the recessive inheritance of the CYP1B1 and LTBP2 forms, and
      contrasts it with the dominant TEK form recorded separately below.
      Evidence source is OTHER because GeneReviews is an expert-curated
      synthesis.
  - reference: PMID:9463332
    reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Formal linkage analysis in 25 Saudi PCG families confirmed both significant linkage to polymorphic markers in this region and incomplete penetrance, but it showed no evidence of genetic heterogeneity."
    explanation: >-
      Documents incomplete penetrance directly in a linkage-confirmed
      GLC3A/CYP1B1 cohort, supporting the penetrance value recorded here.
- name: Autosomal Dominant
  description: >-
    The pattern for TEK-related congenital glaucoma (GLC3E), which acts through
    haploinsufficiency rather than biallelic loss. Expressivity is markedly
    variable, so a heterozygous parent may be unaffected or only mildly affected
    and the pedigree can be mistaken for a sporadic or recessive one.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  expressivity: VARIABLE
  evidence:
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity."
    explanation: >-
      States both the autosomal dominant transmission and the variable
      expressivity recorded on this inheritance block.
genetic:
- name: CYP1B1
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: GLC3A
  notes: >-
    GLC3A locus, 2p21. The most frequently implicated gene in congenital
    glaucoma, but its share of cases is strongly population-dependent, so a
    negative CYP1B1 result carries very different weight in a consanguineous
    founder population than in an outbred one.
  gene_term:
    preferred_term: CYP1B1
    term:
      id: hgnc:2597
      label: CYP1B1
  inheritance:
  - name: Autosomal Recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    penetrance: INCOMPLETE
    evidence:
    - reference: PMID:9463332
      reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Formal linkage analysis in 25 Saudi PCG families confirmed both significant linkage to polymorphic markers in this region and incomplete penetrance, but it showed no evidence of genetic heterogeneity."
      explanation: >-
        Confirms recessive linkage at GLC3A together with the incomplete
        penetrance recorded on this inheritance block.
  case_fractions:
  - population: Genomics England 100,000 Genomes Project childhood glaucoma cohort, molecularly solved families
    case_fraction_percent: 55.0
    cohort_size: 20
    notes: >-
      Share of the twenty solved families in a genomically characterised,
      ethnically diverse UK childhood-glaucoma cohort; this is a fraction of
      solved cases, not of all cases.
    evidence:
    - reference: PMID:38755526
      reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "CYP1B1 was the most frequently implicated gene, accounting for 55% (11/20) of the solved families."
      explanation: >-
        Quantifies the CYP1B1 share among solved families in this cohort.
  evidence:
  - reference: PMID:9097971
    reference_title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mutations detected in the affected members of these families were not present in 470 chromosomes from randomly selected normal individuals, thus strongly suggesting that CYP1B1 is the gene for the GLC3A locus on 2p21."
    explanation: >-
      The original identification of CYP1B1 as the GLC3A gene, with control-panel
      exclusion of the variants.
  - reference: PMID:9463332
    reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sequence analysis of the coding exons for cytochrome P4501B1 (CYP1B1) in these 25 families revealed three distinctive mutations that segregate with the phenotype in 24 families."
    explanation: >-
      Independent confirmation of CYP1B1 as causative with segregation in 24 of
      25 linked families.
  - reference: PMID:38386645
    reference_title: "Genetic changes and testing associated with childhood glaucoma: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CYP1B1 variants were associated with region and population-specific prevalence ranging from 5% to 86% among those with primary congenital glaucoma."
    explanation: >-
      Quantifies the population dependence of the CYP1B1 contribution across 196
      studies, which is the caveat recorded in the notes.
- name: LTBP2
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: GLC3D
  notes: >-
    14q24.3. Biallelic null mutations, reported in consanguineous Pakistani and
    Roma families. Whether LTBP2 is the GLC3C gene itself or a distinct adjacent
    locus remains formally unresolved, which is why GLC3C and GLC3D are curated as
    separate subtypes here.
  gene_term:
    preferred_term: LTBP2
    term:
      id: hgnc:6715
      label: LTBP2
  inheritance:
  - name: Autosomal Recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:19361779
      reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Primary congenital glaucoma (PCG) is an autosomal-recessive condition characterized by high intraocular pressure (IOP), usually within the first year of life, which potentially could lead to optic nerve damage, globe enlargement, and permanent loss of vision."
      explanation: >-
        States the autosomal recessive inheritance of the PCG form in which the
        LTBP2 null mutations reported by this paper segregate.
  evidence:
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity."
    explanation: >-
      Establishes LTBP2 null mutations as causative in the populations named in
      the notes.
  - reference: PMID:19361779
    reference_title: "Null mutations in LTBP2 cause primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG."
    explanation: >-
      Records the authors' own explicit uncertainty about whether LTBP2 is the
      GLC3C gene. Marked PARTIAL because it supports the causal role while
      leaving the locus assignment open.
  - reference: PMID:23218701
    reference_title: "CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "No disease-causing mutations within the LTBP2 and MYOC genes were discovered."
    explanation: >-
      A negative result in a United States PCG cohort. Marked PARTIAL because it
      does not refute LTBP2 causality, established in consanguineous populations,
      but does bound its contribution in outbred cohorts.
- name: TEK
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: GLC3E
  notes: >-
    TIE2, the endothelial angiopoietin receptor. Heterozygous loss-of-function
    variants act by haploinsufficiency, giving autosomal dominant transmission
    with variable expressivity -- the exception among the GLC3 loci, which are
    otherwise recessive.
  gene_term:
    preferred_term: TEK
    term:
      id: hgnc:11724
      label: TEK
  inheritance:
  - name: Autosomal Dominant
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    expressivity: VARIABLE
    evidence:
    - reference: PMID:20301314
      reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Autosomal dominant inheritance. Each child of an individual with TEK-related PCG has a 50% chance of inheriting the pathogenic variant."
      explanation: >-
        States dominant transmission and the 50% recurrence risk specific to
        TEK-related disease. Evidence source is OTHER because GeneReviews is an
        expert-curated synthesis.
  case_fractions:
  - population: International cohort of 189 unrelated primary congenital glaucoma families
    case_fraction_percent: 5.3
    cohort_size: 189
    notes: >-
      Ten of 189 unrelated PCG families carried rare TEK variants; the percentage
      is computed from the reported counts.
    evidence:
    - reference: PMID:27270174
      reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function."
      explanation: >-
        Gives the numerator and denominator from which this case fraction is
        derived.
  evidence:
  - reference: PMID:27270174
    reference_title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Multiple cellular mechanisms were responsible for the loss of protein function resulting from individual TEK variants, including an absence of normal protein production, protein aggregate formation, enhanced proteasomal degradation, altered subcellular localization, and reduced responsiveness to ligand stimulation."
    explanation: >-
      Documents the several distinct cellular routes by which different TEK
      alleles converge on the same haploinsufficient endpoint.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified two novel likely pathogenic variants in the TEK gene, in addition to one novel pathogenic copy number variant (CNV) in FOXC1."
    explanation: >-
      Independent replication of TEK as a childhood-glaucoma gene in a separate
      genomically characterised cohort.
- name: ANGPT1
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: ANGPT1 PCG
  notes: >-
    The principal TEK ligand. Rare variants were found in 3 of 284 PCG subjects,
    with loss of function demonstrated for two of the three alleles; the rarity is
    consistent with ANGPT2 compensating for ANGPT1 loss.
  gene_term:
    preferred_term: ANGPT1
    term:
      id: hgnc:484
      label: ANGPT1
  evidence:
  - reference: PMID:29106382
    reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease."
    explanation: >-
      Reports the functional demonstration of loss of function for the patient
      ANGPT1 alleles and the authors' causality claim.
- name: FOXC1
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: ASD Congenital Glaucoma
  notes: >-
    A forkhead transcription factor acting in the neural-crest-derived periocular
    mesenchyme. Causes Axenfeld-Rieger spectrum disease, in which glaucoma tends
    to begin earlier and show broader variability than in the PITX2 form. Curated
    here as a route into congenital glaucoma; the syndrome itself is
    Axenfeld-Rieger_syndrome.yaml.
  gene_term:
    preferred_term: FOXC1
    term:
      id: hgnc:3800
      label: FOXC1
  evidence:
  - reference: PMID:35882526
    reference_title: "Axenfeld-Rieger syndrome: more than meets the eye."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "128 individuals with causative variants in PITX2 or FOXC1, including 81 new cases, were investigated. Ocular anomalies showed significant overlap but with broader variability and earlier onset of glaucoma for FOXC1-related ARS."
    explanation: >-
      Establishes FOXC1 as causative in the largest reported ARS cohort and
      documents the earlier glaucoma onset that distinguishes it from PITX2.
  - reference: PMID:12624268
    reference_title: "Modification of ocular defects in mouse developmental glaucoma models by tyrosinase."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Tyr also modified the drainage structure dysgenesis in mice with a mutant Foxc1 gene, which is also involved in PCG."
    explanation: >-
      Shows Foxc1 mutation produces modifiable drainage-structure dysgenesis in
      mice, linking this gene to the same developmental lesion as CYP1B1.
- name: PITX2
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: ASD Congenital Glaucoma
  notes: >-
    Homeodomain transcription factor of the anterior segment developmental
    programme; the second Axenfeld-Rieger gene, accompanied by the characteristic
    umbilical and dental systemic features. Curated here only as a route into
    congenital glaucoma.
  gene_term:
    preferred_term: PITX2
    term:
      id: hgnc:9005
      label: PITX2
  evidence:
  - reference: PMID:35882526
    reference_title: "Axenfeld-Rieger syndrome: more than meets the eye."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "128 individuals with causative variants in PITX2 or FOXC1, including 81 new cases, were investigated. Ocular anomalies showed significant overlap but with broader variability and earlier onset of glaucoma for FOXC1-related ARS."
    explanation: >-
      Establishes PITX2 as one of the two causative ARS genes in the largest
      reported cohort.
- name: PAX6
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: ASD Congenital Glaucoma
  notes: >-
    The aniridia gene. Glaucoma in PAX6-related congenital aniridia is a major
    cause of blindness in that population, but its mechanism is unsettled --
    congenital trabecular dysfunction, progressive angle closure, and
    postoperative pressure rise have all been proposed, and the choice matters
    because surgery carries particular risk in aniridic eyes.
  gene_term:
    preferred_term: PAX6
    term:
      id: hgnc:8620
      label: PAX6
  evidence:
  - reference: PMID:39368260
    reference_title: "[Glaucoma in PAX6-related congenital aniridia: A review of the literature]."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Glaucoma remains, along with limbal insufficiency, one of the major causes of blindness in congenital aniridia."
    explanation: >-
      Establishes the clinical weight of glaucoma within PAX6-related congenital
      aniridia. Evidence source is OTHER because this is a literature review.
  - reference: PMID:41936534
    reference_title: "Integrating clinical and genetic insights in anterior segment dysgenesis with glaucoma: A contemporary review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Mutations in key transcriptional and structural genes-including PAX6, FOXC1, PITX2, CYP1B1, LTBP2, PXDN, and GJA8-account for the majority of ASD cases."
    explanation: >-
      Places PAX6 with FOXC1 and PITX2 among the genes accounting for most
      anterior segment dysgenesis, the group curated under this subtype. Evidence
      source is OTHER because this is a systematic review.
- name: SVEP1
  association: Candidate modifier of TEK-related penetrance and severity
  relationship_type: MODIFIER
  variant_origin: GERMLINE
  gene_term:
    preferred_term: SVEP1
    term:
      id: hgnc:15985
      label: SVEP1
  notes: >-
    Candidate modifier of TEK-related penetrance and severity rather than an
    independently validated primary PCG gene. It is curated because the TEK
    entry above records incomplete penetrance and variable expressivity without
    naming a mechanism for that variability, and SVEP1 is the proposed
    mechanism. The hedge is deliberate and matches the source: the supporting
    data are a proposal resting on animal-model expression work, not an
    established diagnostic relationship, and SVEP1 should not be reported as a
    cause of congenital glaucoma on that basis.
  evidence:
  - reference: PMID:38386645
    reference_title: "Genetic changes and testing associated with childhood glaucoma: A systematic review."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: one study has proposed that the SVEP1 gene could be a potent genetic modifier as SVEP1 loss of function alleles were demonstrated to reduce TEK expression in vascular endothelial cells in animal models
    explanation: >-
      States the proposed modifier relationship and, importantly, its basis:
      loss-of-function alleles reducing TEK expression in animal models.
      supports is PARTIAL and evidence_source is MODEL_ORGANISM because the
      claim is a proposal grounded in model-organism expression data rather than
      a demonstrated human genotype-phenotype relationship.
prevalence:
- population: Denmark, nationwide, births 1977-2016
  measure_type: ANNUAL_INCIDENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 4.8
  subtype: PCG
  notes: >-
    Complete national ascertainment over 40 years, restricted to isolated angle
    dysgenesis and excluding glaucoma associated with other congenital
    abnormalities -- so this is a PCG rate, not a childhood-glaucoma rate.
  evidence:
  - reference: PMID:31663689
    reference_title: "Primary congenital glaucoma in Denmark, 1977-2016."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 118 patients were identified, annual incidence of PCG was 4.8 per 100 000 live born."
    explanation: >-
      Gives the nationwide Danish incidence figure recorded here.
- population: Western countries
  measure_type: POINT_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 4.0
  rate_low: 1.5
  rate_high: 10.0
  subtype: PCG
  notes: >-
    Reported as one in 10,000 to 68,000 people in Western countries; converted to
    cases per 100,000 (100000/68000 = 1.5 to 100000/10000 = 10.0), with the
    midpoint recorded as the point estimate.
  evidence:
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Primary congenital glaucoma has a prevalence of one in 10,000-68,000 people in Western countries."
    explanation: >-
      Source of the Western-country range converted here. Evidence source is
      OTHER because this is a clinical review.
- population: Slovakian Roma
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 80.0
  subtype: PCG
  notes: >-
    Reported as 1/1250 in this highly consanguineous founder population
    (100000/1250 = 80). The roughly 20-fold excess over Western rates is the
    clearest demonstration that the population-level burden of congenital
    glaucoma tracks consanguinity and founder CYP1B1 alleles.
  evidence:
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "in highly consanguineous populations such as in Slovakian Roma (1/1250)"
    explanation: >-
      Gives the founder-population rate converted here and names consanguinity as
      the driver.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
treatments:
- name: Angle Surgery (Goniotomy or Trabeculotomy)
  description: >-
    Incision of the dysgenetic trabecular meshwork to open a direct route from the
    anterior chamber into Schlemm canal. Goniotomy requires a clear cornea to
    visualise the angle; trabeculotomy ab externo does not, and is therefore
    preferred when the cornea is edematous, which is common at presentation in
    regions where disease is advanced at diagnosis. This is first-line surgery in
    primary congenital glaucoma and is mechanism-directed rather than
    symptomatic -- it addresses the dysgenetic meshwork itself. Note the
    corollary: where the angle is obliterated by adhesions rather than dysgenetic,
    as in some Peters anomaly eyes, angle incision is much less effective.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_mechanisms:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
    treatment_effect: BYPASSES
    description: >-
      Angle incision creates a direct outflow channel past the dysgenetic
      meshwork rather than restoring normal meshwork development.
    evidence:
    - reference: PMID:39941238
      reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Surgical intervention remains the cornerstone of treatment, and initial surgical options include angle surgeries such as goniotomy and trabeculotomy, aimed at improving aqueous outflow."
      explanation: >-
        States that angle surgery acts by improving aqueous outflow, which is the
        mechanism node targeted here. Evidence source is OTHER because this is a
        clinical review.
  evidence:
  - reference: PMID:26886124
    reference_title: "Updates on the Surgical Management of Pediatric Glaucoma."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Angle surgery is usually the first-line treatment in the surgical management of primary congenital glaucoma because it has a relatively good success rate with a low complication rate."
    explanation: >-
      Establishes angle surgery as first-line, with the risk-benefit reasoning.
      Evidence source is OTHER because this is a surgical review.
  - reference: PMID:38249492
    reference_title: "Approach to primary congenital glaucoma: A perspective."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Angle incision surgery such as goniotomy or trabeculotomy ab externo is the preferred choice of surgery in the Caucasian population."
    explanation: >-
      Supports angle incision as the preferred first operation, and flags the
      population qualification carried in the description. Evidence source is
      OTHER because this is an expert clinical perspective.
  - reference: PMID:30846492
    reference_title: "Factors influencing the outcome of goniotomy and trabeculotomy in primary congenital glaucoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Trabeculotomy seems to be superior to goniotomy in primary congenital glaucoma."
    explanation: >-
      Compares the two angle procedures in a 452-eye series and favours
      trabeculotomy, supporting the preference stated in the description.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Surgery (goniotomy, trabeculotomy, trabeculectomy, or deep sclerectomy) as early as possible; use of drainage implants or cyclodestruction if surgery fails"
    explanation: >-
      GeneReviews management recommendation placing surgery first and as early as
      possible. Evidence source is OTHER because GeneReviews is an expert-curated
      synthesis.
- name: Filtering Surgery and Glaucoma Drainage Devices
  description: >-
    Second-line surgery after failed angle incision: trabeculectomy, usually with
    an antifibrotic agent because the pediatric healing response scars a bleb
    aggressively, or implantation of a glaucoma drainage device. Both create an
    outflow route that bypasses the natural drainage pathway entirely rather than
    repairing it. Cyclodestructive procedures, which reduce aqueous production
    instead of improving egress, are reserved for eyes with poor visual potential.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_mechanisms:
  - target: Congenital Intraocular Pressure Elevation
    treatment_effect: BYPASSES
    description: >-
      A filtering bleb or drainage tube lowers intraocular pressure by routing
      aqueous around the diseased angle altogether.
    evidence:
    - reference: PMID:39941238
      reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "For refractory cases, trabeculectomy and glaucoma drainage devices (GDDs) serve as second-line therapies."
      explanation: >-
        Positions these procedures as second-line pressure-lowering therapy,
        which is the mechanism node targeted. Evidence source is OTHER because
        this is a clinical review.
  evidence:
  - reference: PMID:26886124
    reference_title: "Updates on the Surgical Management of Pediatric Glaucoma."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "After failed angle surgery or in cases of secondary pediatric glaucoma, options such as trabeculectomy, glaucoma drainage devices, or cyclodestructive procedures can be considered"
    explanation: >-
      Sets out the second-line sequence recorded in the description, including
      the place of cyclodestruction. Evidence source is OTHER because this is a
      surgical review.
- name: Topical and Systemic IOP-Lowering Pharmacotherapy
  description: >-
    Medical therapy has a supportive rather than definitive role in congenital
    glaucoma -- the reverse of adult glaucoma practice. It is used to clear the
    cornea before surgery so the angle can be seen, and as an adjunct
    postoperatively when pressure control is incomplete. Safety caveat carried
    from GeneReviews: alpha-2 agonists must be avoided in infants because of the
    risk of apnea and bradycardia, and echothiophate should be stopped before
    surgery to prevent prolonged apnea.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Congenital Intraocular Pressure Elevation
    treatment_effect: INHIBITS
    description: >-
      Reduces aqueous production or increases outflow to lower intraocular
      pressure pending or supplementing definitive surgery.
    evidence:
    - reference: PMID:38249492
      reference_title: "Approach to primary congenital glaucoma: A perspective."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Medical therapy only serves as a supportive role, and surgical intervention remains the principal therapeutic modality."
      explanation: >-
        States the supportive, pressure-directed role of medical therapy relative
        to surgery. Evidence source is OTHER because this is an expert clinical
        perspective.
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Agents/circumstances to avoid: Alpha-2 agonists because of risk for apnea and bradycardia."
    explanation: >-
      The GeneReviews drug-safety warning reproduced in the description. Evidence
      source is OTHER because GeneReviews is an expert-curated synthesis.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Discontinuation of medications such as Phospholine Iodide® (echothiophate) before surgery to prevent prolonged apnea."
    explanation: >-
      The second GeneReviews safety instruction reproduced in the description.
      Evidence source is OTHER because GeneReviews is an expert-curated
      synthesis.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Medical management with both topical and oral drugs can be used as a temporary modality or as an adjunct to surgery, but surgery remains the predominant treatment in order to control the IOP"
    explanation: >-
      Independently confirms the temporary/adjunctive role of medical therapy in
      childhood glaucoma.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- name: Refractive Correction and Amblyopia Therapy
  description: >-
    Spectacles or contact lenses for the myopic and anisometropic shift, together
    with occlusion or other amblyopia therapy during the critical period. This is
    not supportive care around the glaucoma -- it treats a parallel, independently
    sufficient cause of permanent vision loss, and omitting it can leave a child
    with a normal-pressure eye and no useful vision. Low-vision rehabilitation is
    added where impairment is established.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_mechanisms:
  - target: Deprivation and Refractive Amblyopia
    treatment_effect: INHIBITS
    description: >-
      Refractive correction removes the defocus and occlusion therapy counters
      the cortical suppression, addressing the amblyogenic branch directly rather
      than the pressure.
    evidence:
    - reference: PMID:38249492
      reference_title: "Approach to primary congenital glaucoma: A perspective."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Myopia is common among children with PCG, and appropriate optical refractive correction in the form of glasses or contact lenses should be provided. Amblyopia therapy should be instituted to ensure overall visual development in the early developmental years."
      explanation: >-
        Prescribes both refractive correction and amblyopia therapy for exactly
        the mechanism node targeted. Evidence source is OTHER because this is an
        expert clinical perspective.
  evidence:
  - reference: PMID:38249492
    reference_title: "Approach to primary congenital glaucoma: A perspective."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Low-vision rehabilitation services should be provided to children with vision impairment."
    explanation: >-
      Supports the low-vision rehabilitation component of this treatment.
      Evidence source is OTHER because this is an expert clinical perspective.
- name: Genetic Counseling
  description: >-
    Counseling must be mode-specific, since recurrence risk is 25% for the
    recessive CYP1B1 and LTBP2 forms but 50% for dominant TEK-related disease.
    Where a familial variant is known, counseling is delivered alongside the
    cascade testing curated under diagnosis:, which is what changes the
    surveillance plan for an at-risk newborn.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier."
    explanation: >-
      Supports the recessive recurrence risk quoted in the description. Evidence
      source is OTHER because GeneReviews is an expert-curated synthesis.
diagnosis:
- name: Confirmatory molecular genetic testing
  description: >-
    Molecular testing confirms the diagnosis when clinical features are
    inconclusive: biallelic pathogenic variants in CYP1B1 or LTBP2, or a
    heterozygous pathogenic variant in TEK.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Identification of biallelic pathogenic variants in CYP1B1 or LTBP2 or identification of a heterozygous pathogenic variant in TEK confirms the diagnosis if clinical features are inconclusive.
    explanation: >-
      States the confirmatory diagnostic role of molecular testing. Evidence
      source is OTHER because GeneReviews is an expert-curated synthesis rather
      than a primary study.
- name: Cascade testing of at-risk siblings
  description: >-
    Once a familial variant is known, at-risk newborns can be tested directly
    rather than subjected to repeated examinations under anaesthesia. This is
    surveillance triage rather than treatment, and is the practical reason
    molecular diagnosis changes management in this disease.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: molecular genetic testing of at-risk sibs as soon as possible after birth in order to avoid repeated examinations under anesthesia in young children who do not have the pathogenic variant(s).
    explanation: >-
      Gives the sibling-surveillance benefit that makes cascade testing a
      diagnostic and surveillance act. Evidence source is OTHER because
      GeneReviews is an expert-curated synthesis.
- name: Examination Under Anesthesia
  description: >-
    The diagnostic act in congenital glaucoma is a full examination under general
    anaesthesia, because an infant cannot cooperate with tonometry, gonioscopy,
    corneal diameter measurement, axial length measurement, or disc examination
    while awake. The diagnosis rests on the combination -- elevated intraocular
    pressure, globe enlargement, increased corneal diameter, corneal clouding,
    Descemet membrane breaks, and an anomalously deep anterior chamber -- rather
    than on any single measurement, which matters because anaesthesia itself
    perturbs the pressure reading.
  evidence:
  - reference: PMID:38249492
    reference_title: "Approach to primary congenital glaucoma: A perspective."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A proper diagnostic evaluation under anesthesia is advisable for all children who do not cooperate for an office examination."
    explanation: >-
      States the requirement for examination under anaesthesia. Evidence source
      is OTHER because this is an expert clinical perspective.
  - reference: PMID:20301314
    reference_title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The diagnosis of PCG is based on clinical criteria including: elevated IOP in a child typically before age one year, enlargement of the globe, increased corneal diameter, cloudy corneas, breaks in Decsemet"
    explanation: >-
      Enumerates the composite clinical criteria on which diagnosis rests.
      Evidence source is OTHER because GeneReviews is an expert-curated
      synthesis.
  - reference: PMID:39941238
    reference_title: "Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In a young child, cooperation is difficult to establish; therefore, the intraocular pressure may read falsely high"
    explanation: >-
      Supports the caveat that a single pressure reading in an uncooperative
      child is unreliable, which is why the composite criteria are used. Evidence
      source is OTHER because this is a clinical review.
animal_models:
- name: Cyp1b1-null mouse
  species: Mouse
  genotype: Cyp1b1-/-
  publication: PMID:12624268
  description: >-
    Constitutive Cyp1b1 knockout producing ocular drainage-structure
    abnormalities that resemble those described in human primary congenital
    glaucoma. Also the system in which tyrosinase was identified as a modifier
    of the drainage phenotype.
  modeled_mechanisms:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces the maldeveloped conventional outflow pathway that is the
      proximate lesion in CYP1B1-related disease.
    limitations: >-
      Drainage-structure dysgenesis is reported as resembling the human lesion
      rather than as measured intraocular hypertension in this work, and the
      phenotype is modifier-sensitive: severity depends on Tyr genotype, so the
      model's expressivity is strain-dependent rather than a fixed readout.
    evidence:
    - reference: PMID:12624268
      reference_title: "Modification of ocular defects in mouse developmental glaucoma models by tyrosinase."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Here we show that Cyp1b1-/- mice have ocular drainage structure abnormalities resembling those reported in human PCG patients.
      explanation: >-
        States the recapitulation claim and its scope, in the authors' own
        hedged terms.
- name: Angpt1-knockout mouse
  species: Mouse
  genotype: Angpt1 knockout; Angpt1/Angpt2 double knockout
  publication: PMID:29106382
  description: >-
    Angiopoietin-ligand knockouts that fail to develop Schlemm canal normally.
    The double knockout lacks the canal entirely, showing that ANGPT2
    compensates for ANGPT1 loss.
  modeled_mechanisms:
  - target: Angiopoietin-TEK Signaling Insufficiency and Schlemm Canal Hypoplasia
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Reproduces both halves of this node: a hypomorphic Schlemm canal and the
      resulting raised intraocular pressure.
    limitations: >-
      Models the ligand side of the axis, whereas the human disease curated here
      is caused by loss-of-function in the TEK receptor; the compensatory
      ANGPT2 relationship is demonstrated in mouse and is not established in
      humans.
    evidence:
    - reference: PMID:29106382
      reference_title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure.
      explanation: >-
        Directly evidences the canal hypoplasia and the intraocular pressure
        elevation this node asserts.
- name: Zebrafish cyp1b1 knockout
  species: Zebrafish
  genotype: cyp1b1 null
  publication: PMID:39890032
  description: >-
    Zebrafish cyp1b1 knockout, the model behind the geo:GSE272589 dataset
    curated in this entry. It is included specifically because it does NOT
    reproduce the glaucoma phenotype, which is the structural counterpart of the
    cyp1b1_mouse_phenotype_fidelity discussion.
  modeled_mechanisms:
  - target: Trabeculodysgenesis and Congenital Outflow Obstruction
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    description: >-
      Adult mutant eye morphology, including the anterior chamber angle and
      cornea, is indistinguishable from wild type. The model is informative
      about CYP1B1 metabolic function but is not a phenocopy of congenital
      glaucoma, and must not be cited as evidence that CYP1B1 loss produces
      angle dysgenesis.
    limitations: >-
      Species divergence in the Cyp1 family is the authors' own proposed
      explanation: zebrafish carry Cyp1c and Cyp1d enzymes absent from mammals,
      so zebrafish Cyp1b1 may not parallel mammalian CYP1B1 function. The
      negative result therefore bounds what the zebrafish system can be used
      for rather than casting doubt on the human gene-disease relationship.
    evidence:
    - reference: PMID:39890032
      reference_title: "Zebrafish Cyp1b1 knockout alters eye and brain metabolomic profiles, affecting ocular and neurobehavioral function."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: However, adult mutant eye morphology, including glaucoma related tissues like the anterior chamber angles and the cornea, was similar to the wildtype (WT).
      explanation: >-
        States plainly that the glaucoma-relevant ocular anatomy is unaffected
        in the knockout, which is what makes this a FAILS_TO_RECAPITULATE link
        rather than a partial one.
    - reference: PMID:39890032
      reference_title: "Zebrafish Cyp1b1 knockout alters eye and brain metabolomic profiles, affecting ocular and neurobehavioral function."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: their Cyp1b1 may not directly parallel the functions of CYP1B1 in rodents or humans
      explanation: >-
        Gives the authors' species-divergence explanation for the negative
        result, which is the limitation recorded on this link.

clinical_trials:
- name: NCT04683289
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Three-year randomized controlled study comparing
    visco-circumferential-suture-trabeculotomy with conventional trabeculotomy
    in primary congenital glaucoma (51 participants). Directly comparative for
    the angle-surgery treatment this entry curates as first-line.
  target_phenotypes:
  - preferred_term: Ocular hypertension
    term:
      id: HP:0007906
      label: Ocular hypertension
  evidence:
  - reference: clinicaltrials:NCT04683289
    reference_title: "Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy in Primary Congenital Glaucoma: A 3-year Randomized Controlled Study"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: comparing outcomes of Visco-Circumferential-Suture-Trabeculotomy in primary congenital glaucoma to trabeculotomy
    explanation: >-
      Establishes the trial as a head-to-head comparison of two angle-surgery
      techniques in this disease.
- name: NCT03541551
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Randomized controlled study of Ologen collagen matrix as an adjuvant to
    combined trabeculectomy-trabeculotomy in primary congenital glaucoma (44
    participants), testing whether reduced scarring improves bleb survival.
    Relevant to the filtering-surgery treatment, which this entry curates as the
    option used when angle surgery fails.
  target_phenotypes:
  - preferred_term: Ocular hypertension
    term:
      id: HP:0007906
      label: Ocular hypertension
  evidence:
  - reference: clinicaltrials:NCT03541551
    reference_title: Randomized Controlled Study to Evaluate Safety and Efficacy of Ologen Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the purpose of this study is to compare combined trabeculectomy with trabeculotomy (CTT) with adjuvant ologen® Collagen Matrix versus CTT without ologen® in children with PCG
    explanation: >-
      States the trial's comparison, which is why it is relevant to the
      filtering-surgery arm of this entry's treatment set.
- name: NCT04116450
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Prospective interventional study of circumferential trabeculotomy performed
    with an illuminated microcatheter in congenital glaucoma, with intraocular
    pressure as the primary endpoint and corneal diameter and cup-to-disc ratio as
    secondary endpoints -- the two stretch-related measures this entry treats as
    markers of the biomechanical branch.
  target_phenotypes:
  - preferred_term: Ocular hypertension
    term:
      id: HP:0007906
      label: Ocular hypertension
  - preferred_term: Megalocornea
    term:
      id: HP:0000485
      label: Megalocornea
  evidence:
  - reference: clinicaltrials:NCT04116450
    reference_title: "Microcatheter Assisted Circumferential Trabeculotomy in Congenital Glaucoma"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This was a prorospective study of 25 eyes of 25 patients with primary congenital or juvenile glaucoma those underwent circumferential trabeculotomy done with an illuminated microcatheter through a period of 24 months."
    explanation: >-
      Establishes the trial population and the angle-surgery intervention. The
      spelling of "prorospective" is the registry record's own.
- name: NCT06189326
  phase: NOT_APPLICABLE
  status: UNKNOWN
  description: >-
    Comparison of non-penetrating deep sclerectomy against combined
    trabeculotomy-trabeculectomy in primary congenital glaucoma. Relevant to this
    entry's treatment section because the non-penetrating approach leaves a
    trabeculo-descemetic membrane intact, trading some pressure reduction for
    protection against early postoperative hypotony in a small eye.
  target_phenotypes:
  - preferred_term: Ocular hypertension
    term:
      id: HP:0007906
      label: Ocular hypertension
  evidence:
  - reference: clinicaltrials:NCT06189326
    reference_title: "Non-penetrating Deep Sclerectomy Versus Trabeculotomy- Trabeculectomy Operation in Treatment of Primary Congenital Glaucoma"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The aim of this study is to assess the safety and efficacy outcomes of non-penetrating deep sclerectomy versus combined trabeculotomy-trabeculectomy in the treatment of congenital primary glaucoma"
    explanation: >-
      States the trial's comparison of the two surgical approaches in this
      disease.
discussions:
- discussion_id: cyp1b1_expression_site
  kind: CONTROVERSY
  status: OPEN
  prompt: >-
    Is CYP1B1 expressed in the trabecular meshwork itself, or does it act on the
    developing outflow apparatus from the ciliary body and neuroepithelium?
  attaches_to:
  - "pathophysiology#CYP1B1 Deficiency in the Developing Anterior Segment"
  rationale: >-
    The two published answers are directly contradictory. The original GLC3A
    mapping paper reports demonstrating CYP1B1 expression in trabecular meshwork
    cells; a later cohort study states expression is found in fetal and adult
    ciliary body and neuroepithelium but not in the trabecular meshwork, and a
    2024 review describes trabecular expression as controversial. The
    disagreement is mechanistically load-bearing rather than a bookkeeping
    detail: cell-autonomous action within the meshwork implies a different
    therapeutic target from a diffusible metabolite generated elsewhere in the
    anterior segment and acting on the meshwork at a distance. This entry
    therefore records the CYP1B1 node's mechanism as an unresolved metabolic
    route rather than asserting a site of action, and the expression evidence is
    marked PARTIAL.
  proposed_experiments:
  - experiment_id: exp_cg_cyp1b1_expression_scrnaseq
    name: Single-cell transcriptomic mapping of CYP1B1 in the developing human anterior segment
    description: >-
      Single-cell or spatial transcriptomic profiling of human fetal iridocorneal
      angle across the developmental window in which the meshwork forms, reporting
      CYP1B1 per annotated cell type, would settle whether trabecular expression
      exists at the developmentally relevant stage. Both conflicting reports rest
      on bulk or adult tissue, where a transient fetal signal in a small cell
      population could be missed.
  evidence:
  - reference: PMID:9097971
    reference_title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "CYP1B1 gene has previously been mapped within the GLC3A candidate region and its expression in the trabecular meshwork cells has been demonstrated in this study."
    explanation: >-
      The report of trabecular meshwork expression that forms one side of this
      controversy. Evidence source is IN_VITRO because this is a tissue
      expression experiment.
  - reference: PMID:23218701
    reference_title: "CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States."
    supports: REFUTE
    evidence_source: OTHER
    snippet: "Studies have demonstrated its expression in fetal and adult ciliary body and neuroepithelium, but not in the trabecular meshwork."
    explanation: >-
      The opposing statement, denying trabecular expression and placing CYP1B1 in
      the ciliary body and neuroepithelium instead.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
  - reference: PMID:38755526
    reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "its expression in the TM remains controversial"
    explanation: >-
      A contemporary source that characterises the question as still open,
      supporting keeping this discussion OPEN rather than resolving it either
      way.
      Evidence source is OTHER because this statement is citation-bearing
      review prose in the paper's introduction rather than its own study
      result.
- discussion_id: cyp1b1_mouse_phenotype_fidelity
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    How faithfully does the Cyp1b1-null mouse model the human CYP1B1 congenital
    glaucoma phenotype, given that its severity depends on tyrosinase genotype and
    can be pharmacologically rescued?
  attaches_to:
  - "pathophysiology#CYP1B1 Deficiency in the Developing Anterior Segment"
  rationale: >-
    Cyp1b1-null mice do develop ocular drainage structure abnormalities
    resembling human disease, so the model is informative. But the magnitude of
    that dysgenesis is set by a second locus, Tyr, and the severe phenotype in
    doubly deficient eyes is alleviated by administering the tyrosinase product
    L-DOPA. That makes the mouse phenotype a property of a particular strain
    background as much as of CYP1B1 loss. Whether an analogous modifier axis
    operates in humans is unknown, and it bears directly on how much weight the
    mouse rescue result can carry as a therapeutic lead. Human CYP1B1 disease does
    show incomplete penetrance and variable expressivity, which is consistent with
    modifiers existing but does not identify them or establish that the tyrosinase
    pathway is among them.
  proposed_experiments:
  - experiment_id: exp_cg_tyr_modifier_founder_cohort
    name: Test the tyrosinase/L-DOPA axis as a modifier in human CYP1B1 congenital glaucoma
    description: >-
      Genotype pigmentation-pathway loci, TYR foremost, in a cohort of patients
      homozygous for the same founder CYP1B1 allele but discordant for disease
      severity. A founder population is required so that the CYP1B1 allele is held
      constant while severity varies; the Slovakian Roma and Saudi cohorts are the
      natural settings.
  evidence:
  - reference: PMID:12624268
    reference_title: "Modification of ocular defects in mouse developmental glaucoma models by tyrosinase."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The severe dysgenesis in eyes lacking both CYP1B1 and TYR was alleviated by administration of the tyrosinase product dihydroxyphenylalanine (l-dopa)."
    explanation: >-
      Documents the pharmacological rescue whose translational validity this
      mismatch discussion questions.
  - reference: PMID:9463332
    reference_title: "Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These results should stimulate a study of the genetic and environmental events that modify the effects of CYP1B1 mutations in ocular development."
    explanation: >-
      The human authors' own call for modifier studies, consistent with modifiers
      operating in humans but not identifying them. Marked PARTIAL because it
      motivates rather than answers the question.
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    evidence:
    - reference: PMID:38755526
      reference_title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Elevated IOP can consequently cause loss of retinal ganglion cells (RGCs) and a progressive optic neuropathy"
      explanation: >-
        Harrison's has no ophthalmology Part, so glaucoma is assigned to the
        neurologic chapter across the dismech glaucoma entries. Marked PARTIAL
        because this quote supports the underlying claim -- that the disease is
        a progressive optic neuropathy from retinal ganglion cell loss -- rather
        than the textbook chapter assignment itself.
        Evidence source is OTHER because this statement is citation-bearing
        review prose in the paper's introduction rather than its own study
        result.
datasets:
- accession: geo:GSE73263
  title: A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus)
  organism:
    preferred_term: domestic cat
    term:
      id: NCBITaxon:9685
      label: Felis catus
  data_type: BULK_RNA_SEQ
  sample_count: 2
  publication: PMID:27149523
  notes: >-
    Naturally occurring feline primary congenital glaucoma segregating an LTBP2
    mutation, from a breeding colony established for the trait -- directly the
    GLC3C/GLC3D mechanism curated here, in a spontaneous large-eye model rather
    than an engineered rodent one. Accession, title, organism, and sample count
    verified against NCBI E-utilities on 2026-08-20; the values are GEO's own.
- accession: geo:GSE272589
  title: Zebrafish Cyp1b1 knockout alters eye and brain metabolomic profiles, affecting ocular and neurobehavioral function
  organism:
    preferred_term: zebrafish
    term:
      id: NCBITaxon:7955
      label: Danio rerio
  data_type: BULK_RNA_SEQ
  sample_count: 40
  publication: PMID:39890032
  notes: >-
    Cyp1b1 loss-of-function zebrafish, explicitly framed by its authors around
    the unresolved role of CYP1B1 in primary congenital glaucoma -- relevant to
    the metabolic-route question recorded in the cyp1b1_expression_site
    discussion. Verified against NCBI E-utilities on 2026-08-20.
- accession: geo:GSE168200
  title: Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies
  organism:
    preferred_term: house mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: SINGLE_CELL_RNA_SEQ
  sample_count: 3
  publication: PMID:34663817
  notes: >-
    Single-cell transcriptomes of the mouse iridocorneal angle using loss of
    Schlemm canal as the perturbation, with angiopoietin-1 signalling as the
    stated premise -- the cell-resolved counterpart of the ANGPT1/TEK node
    curated here. Verified against NCBI E-utilities on 2026-08-20.
- accession: geo:GSE336875
  title: Pitx2-associated early-onset glaucoma alters corneal innervation and sensory function in a sex-specific manner [RNA-Seq cornea]
  organism:
    preferred_term: house mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: BULK_RNA_SEQ
  sample_count: 20

  notes: >-
    Pitx2 mutant mouse cornea, described by its authors as a model of
    Pitx2-associated developmental glaucoma with anterior segment dysgenesis,
    ocular hypertension and optic neuropathy -- the ASD Congenital Glaucoma
    subtype curated here. No linked publication in GEO at the time of curation.
    Verified against NCBI E-utilities on 2026-08-20.
references:
- reference: PMID:20301314
  title: "Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
  tags:
  - GeneReviews
- reference: PMID:38755526
  title: "Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project."
- reference: PMID:27270174
  title: "Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity."
- reference: PMID:29106382
  title: "Angiopoietin-1 is required for Schlemm's canal development in mice and humans."
- reference: PMID:19361779
  title: "Null mutations in LTBP2 cause primary congenital glaucoma."
- reference: PMID:9097971
  title: "Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21."

📚

References & Deep Research

References

6

PMID:20301314

Primary Congenital Glaucoma - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.

No top-level findings curated for this source.

PMID:38755526

Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.

No top-level findings curated for this source.

PMID:27270174

Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

No top-level findings curated for this source.

PMID:29106382

Angiopoietin-1 is required for Schlemm's canal development in mice and humans.

No top-level findings curated for this source.

PMID:19361779

Null mutations in LTBP2 cause primary congenital glaucoma.

No top-level findings curated for this source.

PMID:9097971

Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.

No top-level findings curated for this source.

Deep Research

1

Falcon ▸

Congenital Glaucoma: Comprehensive Disease-Characteristics Report

Edison Scientific Literature 21 citations 2026-08-20T07:24:01.437194

Congenital Glaucoma: Comprehensive Disease-Characteristics Report

Scope and evidence conventions

“Congenital glaucoma” is sometimes used broadly for glaucoma recognized at or shortly after birth. This report focuses on primary congenital glaucoma (PCG)—the Mendelian, nonsyndromic developmental glaucoma that usually manifests by age 3—and distinguishes it from secondary childhood glaucoma caused by anterior-segment anomalies, systemic syndromes, acquired disease, or cataract surgery. Evidence is aggregated at disease/cohort level; it is not derived from an individual EHR. Mechanistic evidence is labeled as human, animal, or in vitro where appropriate.

The compact curation summary below complements the narrative report.

Domain	Compact summary	Ontology / terminology suggestions	Evidence type	Caveats	Citations
Definition / onset	Primary congenital glaucoma (PCG) is the main primary childhood glaucoma subtype, usually presenting from birth to age 3 years, often within the first 6 months, due to developmental aqueous outflow abnormality causing elevated intraocular pressure (IOP), globe enlargement, and optic neuropathy.	MONDO:0018110; HPO onset suggestions: HP:0003577 Congenital onset, HP:0011463 Childhood onset	Disease review; genomics review; clinical perspective	Some sources discuss “childhood glaucoma” broadly; confirm whether a database entry should be restricted to isolated PCG versus broader primary childhood glaucoma.	(alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 1-2, mandal2023approachtoprimary pages 2-3)
Key identifiers	Suggested disease-level identifiers: MONDO:0018110; OMIM phenotype 231300 / GLC3A; ORPHA:98976; ICD-10 Q15.0; MeSH D005901. These are ontology metadata rather than patient-derived observations.	OMIM/Orphanet/ICD/MeSH/MONDO metadata	Curated ontology metadata	Verify against current ontology releases before KB ingestion; not all were evidenced in retrieved papers.	(coviltir2025primarycongenitaland pages 2-4)
Epidemiology	Reported incidence/prevalence varies widely by ancestry and consanguinity: ~1 in 10,000–68,000 in Western countries; ~1:2500 in Saudi Arabia; ~1:8200 in Palestinian Arabs; ~1:1250 in Slovakian Gypsies. PCG contributes substantially to childhood blindness (about 5–18% globally; 4.2% cited in India). Bilateral disease occurs in ~70%, often asymmetrically.	HPO pattern suggestions: HP:0012837 Bilateral, HP:0012838 Unilateral, HP:0000628 Increased intraocular pressure	Epidemiology review; clinical review	Rates differ because of case definition, registry coverage, and referral bias.	(coviltir2025primarycongenitaland pages 2-4, pan2024exploringthegenetic pages 1-2, mandal2023approachtoprimary pages 2-3, coviltir2025primarycongenitaland pages 1-2)
Principal genes / inheritance	Major PCG genes include CYP1B1 and LTBP2 (typically autosomal recessive), TEK and ANGPT1 (autosomal dominant), and FOXC1 in some developmental/anterior-segment cases; CYP1B1 is the most frequently implicated gene overall and shows marked population-specific prevalence. SVEP1 has evidence as a modifier of TEK-related disease.	Gene symbols: CYP1B1, LTBP2, TEK, ANGPT1, FOXC1, SVEP1; inheritance: AR, AD	Human genetics review; human cohort genomics; model-supported modifier evidence	Genetic architecture is heterogeneous; many cohorts remain unsolved and inheritance can appear complex/digenic in some families.	(alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12, pan2024exploringthegenetic pages 14-15)
Hallmark phenotypes	Classic presentation includes epiphora, photophobia, blepharospasm, corneal edema/haze, enlarged corneal diameter, Haab striae, buphthalmos, myopic shift, elevated IOP, optic disc cupping/asymmetry, and later visual field/vision loss.	HPO suggestions: HP:0000627 Epiphora, HP:0000613 Photophobia, HP:0000652 Blepharospasm, HP:0007957 Corneal edema, HP:0001083 Buphthalmos, HP:0000518 Cataract not core/if present assess secondary causes, HP:0000540 Hypermetropia not typical, HP:0000602 Ophthalmoplegia not typical, HP:0000598 Abnormality of the optic disc, HP:0007686 Increased cup-to-disc ratio, HP:0000541 Myopia, HP:0007906 Haab striae	Clinical review; disease review	Frequency of each sign varies with age at detection and severity; phenotype overlap with secondary childhood glaucoma is common.	(coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3, coviltir2025primarycongenitaland pages 1-2)
Mechanism / anatomy	Core mechanism is developmental malformation of aqueous outflow pathways, especially trabecular meshwork and Schlemm canal. CYP1B1 dysfunction is linked to oxidative-stress and extracellular-matrix dysregulation in trabecular meshwork development; TEK/ANGPT1 signaling is crucial for Schlemm canal endothelial development; LTBP2 implicates extracellular matrix / TGF-β-associated structures; downstream consequence is elevated IOP with retinal ganglion cell injury and optic neuropathy.	GO suggestions: GO:0003151 outflow tract morphogenesis (approximate developmental analog; verify), GO:0030198 extracellular matrix organization, GO:0006979 response to oxidative stress, GO:0001525 angiogenesis, GO:0070934 CRYAB? verify before use, GO:0042060 wound healing not core; CL suggestions: trabecular meshwork cell, endothelial cell of Schlemm canal, retinal ganglion cell, neural crest-derived periocular mesenchymal cell; UBERON suggestions: UBERON:0001769 trabecular meshwork, UBERON:0010414 Schlemm canal, UBERON:0000924 cornea, UBERON:0000966 retina, UBERON:0001780 optic nerve	Human genetics review; mouse/zebrafish/cellular evidence	Several GO/CL/UBERON terms should be checked in the target ontology for exact preferred labels/IDs; zebrafish CYP1B1 models do not fully recapitulate human glaucoma.	(pan2024exploringthegenetic pages 14-15, pan2024exploringthegenetic pages 7-9, gomez2020establishingzebrafishdanio pages 46-51, vasiliou2008roleofcyp1b1 pages 1-2, pan2024exploringthegenetic pages 2-4)
Diagnosis	Diagnosis is clinical and often requires examination under anesthesia (EUA). Common criteria require childhood onset plus at least two features such as IOP >21 mmHg, glaucomatous optic nerve changes, corneal enlargement/Haab striae/edema, progressive myopia, or visual field defects. Gonioscopy is important; differential diagnosis includes megalocornea, keratoglobus, Peters anomaly, sclerocornea, and optic nerve hypoplasia.	HPO diagnostic features as above; NCIT-style test concepts: tonometry, gonioscopy, fundoscopy, axial length measurement, corneal diameter measurement	Clinical review; clinical perspective	Pediatric examination is difficult and often anesthesia-dependent; criteria differ somewhat across sources/CGRN adaptations.	(coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3, coviltir2025primarycongenitaland pages 1-2)
Genetic testing	Gene panels, WES, and WGS can establish a molecular diagnosis, support counseling, and occasionally refine prognosis. In the Genomics England childhood glaucoma cohort, expanded analysis raised solved families to 26%; CYP1B1 accounted for 55% of solved families and novel TEK and FOXC1 variants/CNVs were identified.	Testing concepts: targeted glaucoma panel, WES, WGS, CNV analysis	Human cohort genomics; systematic review	Diagnostic yield remains incomplete; non-coding variants, CNVs, and panel limitations can reduce sensitivity.	(alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12)
Treatment algorithm	Surgery is the cornerstone. Initial treatment is usually angle surgery: goniotomy or trabeculotomy; combined trabeculotomy-trabeculectomy is often favored in severe edematous/megalocornea presentations in some regions. Refractory cases may need trabeculectomy with antifibrotics or glaucoma drainage devices; cyclodestructive procedures are generally reserved for poor-visual-potential/advanced cases. Medical therapy is supportive/temporary rather than definitive.	NCIT suggestions: Goniotomy, Trabeculotomy, Trabeculectomy, Glaucoma Drainage Device Implantation, Cyclophotocoagulation, Mitomycin C therapy	Clinical perspective; review; interventional trial registry	Surgical choice varies by corneal clarity, age, severity, and regional practice; high-quality randomized evidence remains limited.	(coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3, NCT04116450 chunk 1, NCT03541551 chunk 1, NCT04683289 chunk 1, NCT06189326 chunk 1)
Prognosis / outcomes	With timely treatment, prognosis can be favorable: stationary disease reported in 90.3% at 1 year, 70.8% at 10 years, and 58.3% at 34 years; median better-eye visual acuity reported as 20/30. Earlier presentation/intervention tends to improve angle-surgery success. Quality of life is reduced overall but tracks with visual acuity.	Outcome concepts: vision preservation, amblyopia prevention, low-vision rehabilitation	Review synthesis	Long-term results depend on age at diagnosis, corneal disease, surgical control, amblyopia management, and follow-up adherence.	(coviltir2025primarycongenitaland pages 1-2, coviltir2025primarycongenitaland pages 10-11)
Prevention / counseling	No general primary prevention is established for sporadic cases, but in high-risk/consanguineous families, genetic counseling, cascade testing, reproductive counseling, and early ophthalmic screening of relatives/newborns can reduce diagnostic delay and support family planning. Secondary prevention centers on rapid recognition of epiphora/photophobia/blepharospasm and urgent referral.	Counseling concepts: genetic counseling, carrier testing, cascade screening, prenatal/preimplantation options where locally available	Public-health review; genetics review; clinical perspective	Evidence is stronger for counseling/early detection than for population-wide screening programs.	(alsaei2024increasingthediagnostic pages 1-2, mandal2023approachtoprimary pages 2-3)
Recent developments (2023–2024)	Notable recent advances include broader childhood-glaucoma genetic syntheses (2024), improved genome-analysis pipelines revealing missed TEK/FOXC1/CNV diagnoses (2024), and exploratory AI/deep-learning image models for pediatric glaucoma detection with reported sensitivity 0.85 and specificity 0.94. Multiple ongoing/recent PCG surgical trials compare trabeculotomy variants, adjunctive Ologen, and deep sclerectomy.	Methods terms: AI-assisted screening, WGS reanalysis, CNV detection	Recent reviews, genomics study, clinical trials	AI performance requires external validation; many trials are single-center and procedure-specific.	(alsaei2024increasingthediagnostic pages 1-2, coviltir2025primarycongenitaland pages 1-2, NCT03541551 chunk 1, NCT04683289 chunk 1, NCT06189326 chunk 1)
Models / comparative biology	Mouse models support CYP1B1-related trabecular meshwork defects and TEK/ANGPT1-dependent Schlemm canal development with IOP elevation and retinal ganglion cell loss. Zebrafish cyp1b1 knockout shows craniofacial/ECM phenotypes and incomplete penetrance but does not fully reproduce human glaucoma, highlighting species differences.	Model systems: mouse knockout/conditional models, zebrafish CRISPR knockout, endothelial cell assays	Model organism and in vitro evidence	Model validity is pathway-specific rather than full-phenotype complete.	(pan2024exploringthegenetic pages 14-15, pan2024exploringthegenetic pages 7-9, gomez2020establishingzebrafishdanio pages 46-51, vasiliou2008roleofcyp1b1 pages 1-2)

Table: This table condenses the highest-yield disease characteristics for primary congenital glaucoma, including identifiers, genetics, mechanism, diagnosis, management, and models. It is designed as a compact curation aid and flags where ontology metadata or mechanistic interpretations should be verified before database ingestion.

1. Disease information

Definition and classification

PCG is a severe developmental optic neuropathy caused by malformed aqueous-humor outflow structures. Impaired drainage raises intraocular pressure (IOP), stretching the compliant infant eye and producing corneal enlargement, buphthalmos, and ultimately retinal ganglion-cell/optic-nerve injury. PCG is defined clinically by onset in early childhood—typically birth to age 3—without another ocular or systemic disorder sufficient to explain the glaucoma. Most children present within the first 6 months. The Childhood Glaucoma Research Network classifies PCG under primary childhood glaucoma, separate from juvenile open-angle glaucoma and secondary childhood glaucomas. (alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 1-2, mandal2023approachtoprimary pages 2-3)

Identifiers and synonyms

Suggested current metadata are MONDO:0018110, OMIM 231300/GLC3A, ORPHA:98976, ICD-10-CM Q15.0, and MeSH D005901. These identifiers should be checked against the release used by the target knowledge base because terminology mappings change and the retrieved primary papers did not independently establish every identifier. Common names are primary congenital glaucoma, congenital glaucoma, infantile glaucoma, trabeculodysgenesis-associated glaucoma, and historically hydrophthalmos/buphthalmos. “Buphthalmos” properly describes the enlarged globe, not the entire disease.

2. Etiology, risk, and protective factors

Causal factors

PCG is primarily genetic and developmental. The strongest genes are CYP1B1 and LTBP2 (usually autosomal recessive) and TEK and ANGPT1 (usually autosomal dominant). FOXC1 can produce developmental glaucoma or an overlapping anterior-segment dysgenesis phenotype. CYP1B1 is the predominant known cause, but its contribution varies markedly by ancestry: a 2024 systematic review found reported CYP1B1 prevalence of approximately 5–86% across PCG populations. In the 100,000 Genomes childhood-glaucoma cohort, CYP1B1 accounted for 55% of molecularly solved families. (alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12)

Genetic risk and modifiers

Consanguinity and an affected sibling or parent are major risk indicators. Only about 10–40% of PCG is reported as familial, however, so absence of family history does not exclude a Mendelian cause. TEK disease shows incomplete penetrance and variable expressivity; SVEP1 has experimental and familial evidence as a modifier of TEK expression and disease severity. Possible digenic/modifier relationships involving CYP1B1 with MYOC or TEK have been proposed but are not established as routine diagnostic models. (alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12, pan2024exploringthegenetic pages 14-15)

Pathogenic alleles include missense, nonsense, frameshift, splice, deletion/CNV, and other loss-of-function variants. The relevant origin is germline, not somatic. Truly pathogenic recessive alleles are generally rare in population databases; no universal carrier frequency is appropriate because founder alleles and consanguinity create strong population differences. Variant-specific gnomAD frequency and ClinVar/ACMG classification should therefore be stored rather than a single disease-wide frequency.

Environmental, lifestyle, infectious, and protective factors

No toxin, infection, diet, smoking behavior, or occupational exposure is accepted as a primary cause of isolated PCG. Environmental epidemiology is sparse and does not support actionable lifestyle prevention. The main “protective” factors are not biologic alleles or exposures, but early recognition, prompt IOP-lowering surgery, refractive correction, amblyopia treatment, and sustained follow-up, which reduce preventable visual loss. Evidence for clinically meaningful gene–environment interaction or protective variants remains insufficient.

3. Phenotypes

The characteristic symptom triad is epiphora, photophobia, and blepharospasm. Signs include corneal edema/haze, enlarged corneal diameter, horizontal Descemet-membrane breaks (Haab striae), buphthalmos, elevated IOP, progressive axial elongation/myopia, optic-disc cupping, rim loss, and later visual-field or visual-acuity loss. PCG is bilateral in approximately 70%, but severity is often asymmetric. (mandal2023approachtoprimary pages 2-3)

Suggested phenotype terms include epiphora (HP:0000627), photophobia (HP:0000613), blepharospasm (HP:0000652), corneal edema (HP:0007957), buphthalmos (HP:0001083), myopia (HP:0000541), increased IOP (HP:0000628), abnormal optic disc (HP:0000598), and increased cup-to-disc ratio (HP:0007686). Exact HPO identifiers and preferred labels should be validated before ingestion.

Severity is variable and progressive without treatment. Corneal enlargement is particularly useful in infants: normal horizontal diameter is about 10 mm at birth; concerning thresholds include ≥11 mm in a newborn, >12 mm before age 1, and >13 mm at any age. Symptoms, repeated anesthesia, spectacles/contact lenses, amblyopia treatment, surgery, and fear of blindness affect both child and caregiver quality of life. Better visual acuity correlates with better quality of life, but validated PCG-specific patient-reported outcome data remain limited. (mandal2023approachtoprimary pages 2-3, coviltir2025primarycongenitaland pages 1-2)

4. Genetic and molecular information

CYP1B1: cytochrome-P450 monooxygenase; principally biallelic loss of function. More than 200 variants have been reported. Missense changes may impair heme binding, folding, stability, or catalytic activity; truncating/splice alleles usually abolish function. Human genetic evidence is strong.
LTBP2: biallelic loss-of-function alleles disrupt extracellular microfibrils and ciliary-zonule/outflow architecture; association with TGF-β-related extracellular-matrix biology is plausible, although LTBP2 does not simply function as a conventional latent-TGF-β carrier in every context. Human genetic and mouse evidence support causality.
TEK/TIE2 and ANGPT1: heterozygous loss-of-function/haploinsufficiency impairs angiopoietin–TEK signaling required for Schlemm-canal endothelial development. Penetrance is incomplete and expressivity variable.
FOXC1: heterozygous dosage or functional defects impair neural-crest/periocular-mesenchyme programs and anterior-segment formation. FOXC1 more often causes an anterior-segment dysgenesis spectrum, including Axenfeld–Rieger phenotypes, than strictly isolated PCG.
SVEP1: candidate modifier of TEK-related penetrance/severity, not an independently validated common PCG gene. (pan2024exploringthegenetic pages 14-15, pan2024exploringthegenetic pages 7-9, gomez2020establishingzebrafishdanio pages 46-51)

A 2024 Japanese study found CYP1B1 variants in 9 of 29 childhood-glaucoma families, including novel p.A202T, p.D274E, p.Q340, and p.V420G, and novel heterozygous FOXC1 variants p.Q23fs, p.Q70R, and p.E163. The observations illustrate population specificity and the need for ACMG/AMP assessment rather than assuming pathogenicity from novelty alone.

No reproducible PCG-specific methylation, histone, repeat-expansion, mitochondrial, or somatic-mutation mechanism is established. Large FOXC1 CNVs can be causal, so copy-number analysis should not be omitted. In the 100,000 Genomes study, expanded analysis increased solved families from 17% to 26%, identifying missed TEK variants and a pathogenic FOXC1 CNV; smaller panels and prioritization of coding SNVs/indels had missed structural, CNV, and noncoding candidates. (alsaei2024increasingthediagnostic pages 1-2)

5. Mechanism and pathophysiology

The principal causal chain is:

developmental gene defect → trabecular-meshwork/Schlemm-canal dysgenesis → increased aqueous outflow resistance → elevated IOP → infant globe and corneal stretching → buphthalmos, Haab striae, edema, axial myopia → retinal ganglion-cell axonal injury and optic-nerve cupping → irreversible visual-field and acuity loss.

CYP1B1 appears upstream in fetal trabecular-meshwork development, oxidative homeostasis, extracellular-matrix regulation, and metabolism of endogenous retinoids, steroids, arachidonate, and melatonin. Cyp1b1-deficient mice develop abnormal trabecular meshwork and Schlemm canal and greater susceptibility to pressure-induced axonopathy. (vasiliou2008roleofcyp1b1 pages 1-2, pan2024exploringthegenetic pages 2-4)

TEK is expressed by Schlemm-canal endothelium; ANGPT1 promotes TEK activation, endothelial survival, and vessel stability. Conditional Tek or angiopoietin deletion in mice causes canal loss, ocular hypertension, and rapid retinal ganglion-cell injury. One model reported IOP of 35.58 ±2.01 mmHg after combined angiopoietin deletion versus 23.53 ±1.50 mmHg with Angpt1 deletion alone. This is animal-model evidence, not a human clinical threshold. (pan2024exploringthegenetic pages 7-9)

Relevant suggested processes are extracellular-matrix organization (GO:0030198), response to oxidative stress (GO:0006979), endothelial development/angiogenesis (GO:0001525), neural-crest development, aqueous-humor outflow, and retinal ganglion-cell death. Relevant cells are trabecular-meshwork cells, Schlemm-canal endothelial cells, neural-crest-derived periocular mesenchyme, corneal endothelial cells, and retinal ganglion cells. Exact CL identifiers should be validated.

No validated clinical metabolomic, lipidomic, proteomic, single-cell, spatial-transcriptomic, or integrated multi-omic signature currently diagnoses PCG. Zebrafish transcriptomics implicates extracellular matrix, adhesion, proliferation, lipid/retinoid metabolism, oxidation–reduction, and inflammation, but translation to human disease remains uncertain. (pan2024exploringthegenetic pages 14-15, gomez2020establishingzebrafishdanio pages 46-51)

6–7. Anatomy and localization

The primary organ is the eye, especially the iridocorneal angle, trabecular meshwork, Schlemm canal, cornea, sclera, anterior chamber, optic nerve head, retina, and retinal ganglion-cell axons. Suggested anatomy terms include trabecular meshwork (UBERON:0001769), cornea (UBERON:0000964; verify release), retina (UBERON:0000966), and optic nerve (UBERON:0001780). Subcellular dysfunction can involve CYP1B1-associated endoplasmic-reticulum/microsomal enzyme activity and nuclear FOXC1 transcriptional regulation. Disease is usually bilateral but asymmetric; no consistent right/left preference is known. There is ordinarily no direct extraocular organ involvement in isolated PCG.

8–9. Temporal development, inheritance, and population epidemiology

Onset is congenital or infantile, usually insidious and progressive. Untreated disease does not remit spontaneously. Early stages feature tearing, photophobia, corneal haze, and IOP elevation; intermediate disease produces globe enlargement, Haab striae, myopia, and optic cupping; advanced disease causes corneal scarring, profound optic neuropathy, amblyopia, and irreversible blindness.

Reported frequency varies from roughly 1 per 10,000–68,000 in Western populations to approximately 1:2,500 in Saudi Arabia, 1:8,200 in Palestinian Arabs, and 1:1,250 in Slovakian Roma, largely reflecting founder effects and consanguinity. Males are slightly overrepresented in many sporadic cohorts, whereas familial cases may approach equal sex distribution. PCG contributes about 5–18% of childhood blindness in published syntheses. (coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3, coviltir2025primarycongenitaland pages 1-2)

CYP1B1/LTBP2 disease implies a 25% recurrence risk for each pregnancy when both parents are confirmed carriers. TEK/ANGPT1/FOXC1 disease can imply a 50% transmission risk from a heterozygous parent, modified by incomplete penetrance and variable expressivity. Anticipation is not established. Germline mosaicism is theoretically possible but not a defining feature. Founder effects and consanguinity are important; carrier frequency must be calculated for the relevant population and variant.

10. Diagnostics

Clinical evaluation

A complete examination—often under anesthesia—includes tonometry, horizontal corneal diameter, pachymetry where feasible, corneal inspection, gonioscopy, axial length/refraction, dilated optic-nerve examination, and serial photography or OCT when technically possible. An accepted CGRN-style diagnosis requires childhood glaucoma with at least two findings such as IOP >21 mmHg, optic-nerve cupping/asymmetry or rim thinning, progressive myopia/axial enlargement, corneal enlargement/edema/Haab striae, or reproducible visual-field loss. (coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3)

Differential diagnoses include isolated megalocornea, keratoglobus, birth-trauma Descemet tears, Peters anomaly, sclerocornea, congenital hereditary endothelial dystrophy, mucopolysaccharidosis, optic-nerve hypoplasia, retinoblastoma-associated glaucoma, steroid/uveitic glaucoma, and glaucoma associated with aniridia, Axenfeld–Rieger syndrome, Sturge–Weber syndrome, or congenital cataract surgery. (coviltir2025primarycongenitaland pages 1-2)

Genetic testing

Recommended testing begins with a childhood-glaucoma/anterior-segment panel containing at least CYP1B1, LTBP2, TEK, ANGPT1, and FOXC1, with deletion/duplication analysis. Broader genes should be included when syndromic or anterior-segment findings are present. If negative, trio WES or preferably WGS with CNV, structural, splice, and noncoding analysis is reasonable. CMA is useful when developmental delay, congenital anomalies, or suspected chromosomal imbalance accompanies glaucoma. Karyotype/FISH are targeted tests, not routine first-line assays. Mitochondrial and repeat-expansion testing are not generally indicated. (alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12)

No biochemical blood test or liquid-biopsy biomarker confirms PCG. Cascade examination and variant testing are appropriate for relatives after a molecular diagnosis. Population newborn biochemical screening is not available.

11. Outcomes and prognosis

PCG does not materially shorten life expectancy; morbidity is visual. Reported stationary disease declined from 90.3% at 1 year to 70.8% at 10 years and 58.3% at 34 years, demonstrating the need for lifelong surveillance. Median better-eye visual acuity of 20/30 has been reported in appropriately managed cohorts, but severe bilateral impairment remains possible. Angle-surgery success was approximately 90% for presentation at 2–12 months versus 50% in later-onset cases in one synthesis. Prognosis worsens with advanced corneal enlargement/scarring, severe initial optic neuropathy, delayed surgery, uncontrolled IOP, repeated operations, anisometropia/amblyopia, and poor follow-up. (coviltir2025primarycongenitaland pages 10-11)

12. Treatment and current implementation

Surgery is definitive first-line treatment. Clear corneas commonly permit goniotomy; trabeculotomy, including circumferential microcatheter/suture techniques, bypasses limited gonioscopic visibility. Severe edematous/megalocornea presentations in India and the Middle East are often treated with combined trabeculotomy–trabeculectomy, sometimes with mitomycin C. Refractory disease may require trabeculectomy, a glaucoma drainage device, or repeat angle surgery. Cyclophotocoagulation is usually reserved for advanced or poor-visual-potential eyes. (coviltir2025primarycongenitaland pages 2-4, mandal2023approachtoprimary pages 2-3)

Topical beta-blockers, carbonic-anhydrase inhibitors, prostaglandin analogues, and selected other agents are bridges to surgery or adjuncts afterward, not cures for dysgenesis. Drug choice requires pediatric systemic-safety attention. Optical correction, amblyopia therapy, corneal care, low-vision rehabilitation, educational support, and caregiver counseling are essential.

Real-world trials include completed microcatheter circumferential trabeculotomy (NCT04116450, 25 eyes), randomized circumferential suture trabeculotomy versus rigid-probe viscotrabeculotomy (NCT04683289, 51 participants), and Ologen-assisted versus unaugmented combined trabeculotomy–trabeculectomy (NCT03541551, 44 participants). Another 40-participant study compared nonpenetrating deep sclerectomy with combined trabeculotomy–trabeculectomy (NCT06189326). These studies use IOP control, medication burden, corneal diameter, axial length, cup-to-disc ratio, and complications as outcomes. (NCT04116450 chunk 1, NCT03541551 chunk 1, NCT04683289 chunk 1, NCT06189326 chunk 1)

No approved gene, cell, RNA, or genotype-directed pharmacologic therapy currently corrects PCG. Pharmacogenomic prescribing standards are unavailable.

Suggested NCIT intervention concepts are goniotomy, trabeculotomy, trabeculectomy, glaucoma drainage-device implantation, cyclophotocoagulation, mitomycin C, refraction correction, and low-vision rehabilitation; exact NCIT codes should be release-validated.

13. Prevention

There is no vaccine or lifestyle-based primary prevention. For known familial disease, genetic counseling should cover inheritance, penetrance, recurrence, carrier/cascade testing, and locally available prenatal or preimplantation genetic testing. At-risk newborns require early ophthalmic examination even if asymptomatic. Secondary prevention consists of caregiver/professional education about tearing, light sensitivity, eyelid squeezing, corneal haze, or an enlarging eye and urgent referral. Tertiary prevention comprises durable IOP control, amblyopia treatment, refractive correction, protection of the better eye, and lifelong monitoring.

14–15. Other species and models

Naturally occurring congenital glaucoma is reported in veterinary medicine, particularly in some dog breeds, but the retrieved evidence did not support reliable breed/VBO, variant, or incidence annotations; these should not be populated without an OMIA/veterinary-specific review. PCG is noninfectious and has no zoonotic transmission.

Mouse models provide the strongest mechanistic validation. Cyp1b1-null mice show trabecular-meshwork/Schlemm-canal abnormalities and oxidative-stress susceptibility; conditional Tek or Angpt deletion produces Schlemm-canal loss, ocular hypertension, buphthalmos, and retinal ganglion-cell injury. Zebrafish cyp1b1 knockout is useful for developmental and transcriptomic studies but does not faithfully reproduce glaucoma: adult craniofacial defects showed incomplete penetrance, and no glaucoma phenotype was observed. Thus it is a pathway model rather than a complete phenocopy. (pan2024exploringthegenetic pages 14-15, pan2024exploringthegenetic pages 7-9, gomez2020establishingzebrafishdanio pages 46-51, vasiliou2008roleofcyp1b1 pages 1-2)

Recent 2023–2024 developments and expert assessment

The most consequential recent development is improved genome interpretation rather than a new therapy. The 2024 100,000 Genomes reanalysis showed that expanding gene lists and interrogating CNVs, structural variants, and noncoding regions increased diagnostic yield to 26%, while a 2024 systematic review identified 53 genes discussed across childhood-glaucoma literature and emphasized the absence of standardized testing guidelines. (alsaei2024increasingthediagnostic pages 1-2, pan2024exploringthegenetic pages 11-12)

Exploratory deep-learning analysis of gaze photographs achieved reported sensitivity 0.85 and specificity 0.94, but external validation and evaluation across ancestries, ages, corneal opacity, and imaging devices are required before population screening. (coviltir2025primarycongenitaland pages 1-2)

The prevailing expert position is that rapid clinical recognition and surgery remain more immediately vision-saving than molecular diagnosis, while genomic testing adds value for etiologic classification, recurrence counseling, detecting syndromic disease, and future precision trials. Major research gaps are unsolved families, penetrance modifiers, validated functional assays for variants of uncertain significance, standardized patient-reported outcomes, prospective comparative surgery trials, and human single-cell/spatial characterization of the developing outflow tract.

Selected recent sources and abstract-supported statements

Al-Saei et al., BMC Genomics, May 2024, DOI: https://doi.org/10.1186/s12864-024-10353-8. Abstract: “This analysis effectively raises the total number of solved CG families in the GE100KGP to 26%.” (alsaei2024increasingthediagnostic pages 1-2)
Pan and Iwata, Children, April 2024, DOI: https://doi.org/10.3390/children11040454. The review identifies CYP1B1, LTBP2, TEK, ANGPT1, and FOXC1 as central PCG genes and integrates relevant animal pathways. (pan2024exploringthegenetic pages 11-12, pan2024exploringthegenetic pages 7-9)
Mandal et al., Taiwan Journal of Ophthalmology, October 2023, DOI: https://doi.org/10.4103/tjo.tjo-d-23-00104. Abstract: “Medical therapy only serves as a supportive role, and surgical intervention remains the principal therapeutic modality.” (mandal2023approachtoprimary pages 2-3)
Kumar et al., PLOS ONE, February 2024, DOI: https://doi.org/10.1371/journal.pone.0298883. The systematic review screened 1,916 records, included 196 studies, and found that CYP1B1 prevalence varied by region and population. (pan2024exploringthegenetic pages 11-12)

PMIDs were not consistently present in the retrieved full-text metadata; DOI URLs are therefore supplied rather than risking incorrect PMID assignment.

References

(alsaei2024increasingthediagnostic pages 1-2): Omayma Al-Saei, Samantha Malka, Nicholas Owen, Elbay Aliyev, Fazulur Rehaman Vempalli, Paulina Ocieczek, Bashayer Al-Khathlan, Khalid Fakhro, and Mariya Moosajee. Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 genomes project. BMC Genomics, May 2024. URL: https://doi.org/10.1186/s12864-024-10353-8, doi:10.1186/s12864-024-10353-8. This article has 5 citations and is from a peer-reviewed journal.
(pan2024exploringthegenetic pages 1-2): Yang Pan and Takeshi Iwata. Exploring the genetic landscape of childhood glaucoma. Children, 11:454, Apr 2024. URL: https://doi.org/10.3390/children11040454, doi:10.3390/children11040454. This article has 18 citations.
(mandal2023approachtoprimary pages 2-3): Anil Kumar Mandal, Debasis Chakrabarti, and Vijaya K. Gothwal. Approach to primary congenital glaucoma: a perspective. Oct 2023. URL: https://doi.org/10.4103/tjo.tjo-d-23-00104, doi:10.4103/tjo.tjo-d-23-00104. This article has 22 citations.
(coviltir2025primarycongenitaland pages 2-4): Valeria Coviltir, Maria Cristina Marinescu, Bianca Maria Urse, and Miruna Gabriela Burcel. Primary congenital and childhood glaucoma—a complex clinical picture and surgical management. Diagnostics, 15:308, Jan 2025. URL: https://doi.org/10.3390/diagnostics15030308, doi:10.3390/diagnostics15030308. This article has 13 citations.
(coviltir2025primarycongenitaland pages 1-2): Valeria Coviltir, Maria Cristina Marinescu, Bianca Maria Urse, and Miruna Gabriela Burcel. Primary congenital and childhood glaucoma—a complex clinical picture and surgical management. Diagnostics, 15:308, Jan 2025. URL: https://doi.org/10.3390/diagnostics15030308, doi:10.3390/diagnostics15030308. This article has 13 citations.
(pan2024exploringthegenetic pages 11-12): Yang Pan and Takeshi Iwata. Exploring the genetic landscape of childhood glaucoma. Children, 11:454, Apr 2024. URL: https://doi.org/10.3390/children11040454, doi:10.3390/children11040454. This article has 18 citations.
(pan2024exploringthegenetic pages 14-15): Yang Pan and Takeshi Iwata. Exploring the genetic landscape of childhood glaucoma. Children, 11:454, Apr 2024. URL: https://doi.org/10.3390/children11040454, doi:10.3390/children11040454. This article has 18 citations.
(pan2024exploringthegenetic pages 7-9): Yang Pan and Takeshi Iwata. Exploring the genetic landscape of childhood glaucoma. Children, 11:454, Apr 2024. URL: https://doi.org/10.3390/children11040454, doi:10.3390/children11040454. This article has 18 citations.
(gomez2020establishingzebrafishdanio pages 46-51): Jurgienne Arizza Gomez Umali. Establishing zebrafish, danio rerio, as a genetic model for glaucoma. Text, 2020. URL: https://doi.org/10.48336/k82g-gr50, doi:10.48336/k82g-gr50. This article has 0 citations and is from a peer-reviewed journal.
(vasiliou2008roleofcyp1b1 pages 1-2): Vasilis Vasiliou and Frank J. Gonzalez. Role of cyp1b1 in glaucoma. Annual Review of Pharmacology and Toxicology, 48:333-358, Feb 2008. URL: https://doi.org/10.1146/annurev.pharmtox.48.061807.154729, doi:10.1146/annurev.pharmtox.48.061807.154729. This article has 268 citations and is from a highest quality peer-reviewed journal.
(pan2024exploringthegenetic pages 2-4): Yang Pan and Takeshi Iwata. Exploring the genetic landscape of childhood glaucoma. Children, 11:454, Apr 2024. URL: https://doi.org/10.3390/children11040454, doi:10.3390/children11040454. This article has 18 citations.
(NCT04116450 chunk 1): Shaaban Elwan. MicrocatheterTrabeculotomy in Primary Congenital Glaucoma. Minia University. 2017. ClinicalTrials.gov Identifier: NCT04116450
(NCT03541551 chunk 1): HERF. Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy. L.V. Prasad Eye Institute. 2018. ClinicalTrials.gov Identifier: NCT03541551
(NCT04683289 chunk 1): Visco-Circumferential-Suture-Trabeculotomy Versus Trabeculotomy. Mansoura University. 2015. ClinicalTrials.gov Identifier: NCT04683289
(NCT06189326 chunk 1): Ehab Tharwat. Non-penetrating Deep Sclerectomy Versus Trabeculotomy- Trabeculectomy Operation in Treatment of Primary Congenital Glaucoma. Al-Azhar University. 2022. ClinicalTrials.gov Identifier: NCT06189326
(coviltir2025primarycongenitaland pages 10-11): Valeria Coviltir, Maria Cristina Marinescu, Bianca Maria Urse, and Miruna Gabriela Burcel. Primary congenital and childhood glaucoma—a complex clinical picture and surgical management. Diagnostics, 15:308, Jan 2025. URL: https://doi.org/10.3390/diagnostics15030308, doi:10.3390/diagnostics15030308. This article has 13 citations.

Artifacts

Edison artifact artifact-00

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	7
Resolved	7
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	7
On topic	7
Off topic	0

All extracted references resolved successfully.

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Subtypes

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Related Datasets

Clinical Trials

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Congenital Glaucoma: Comprehensive Disease-Characteristics Report

Scope and evidence conventions

1. Disease information

Definition and classification

Identifiers and synonyms

2. Etiology, risk, and protective factors

Causal factors

Genetic risk and modifiers

Environmental, lifestyle, infectious, and protective factors

3. Phenotypes

4. Genetic and molecular information

5. Mechanism and pathophysiology

6–7. Anatomy and localization

8–9. Temporal development, inheritance, and population epidemiology

10. Diagnostics

Clinical evaluation

Genetic testing

11. Outcomes and prognosis

12. Treatment and current implementation

13. Prevention

14–15. Other species and models

Recent 2023–2024 developments and expert assessment

Selected recent sources and abstract-supported statements

Artifacts

Reference Validation